These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
¨
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
Delaware
|
63-1261433
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(IRS Employer Identification No.)
|
|
|
|
|
100 Brookwood Place, Birmingham, AL
|
35209
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
|
|
|
(205) 877-4400
|
|
|
(Registrant’s Telephone Number,
Including Area Code)
|
(Former Name, Former Address, and Former
Fiscal Year, if Changed Since Last Report)
|
|
Large accelerated filer
|
|
ý
|
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
|
|
¨
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
|
¨
|
|
|
|
|
|
|
Term
|
Meaning
|
|
AOCI
|
Accumulated other comprehensive income (loss)
|
|
ASU
|
Accounting Standards Update
|
|
BEAT
|
Base erosion anti-abuse tax
|
|
Board
|
Board of Directors of ProAssurance Corporation
|
|
BOLI
|
Business owned life insurance
|
|
Council of Lloyd's
|
The governing body for Lloyd's of London
|
|
DPAC
|
Deferred policy acquisition costs
|
|
Eastern Re
|
Eastern Re, LTD, S.P.C.
|
|
EBUB
|
Earned but unbilled premium
|
|
FAL
|
Funds at Lloyd's
|
|
FASB
|
Financial Accounting Standards Board
|
|
FHLB
|
Federal Home Loan Bank
|
|
FHLMC
|
Federal Home Loan Mortgage Corporation
|
|
FNMA
|
Federal National Mortgage Association
|
|
GAAP
|
Generally accepted accounting principles in the United States of America
|
|
GNMA
|
Government National Mortgage Association
|
|
HCPL
|
Healthcare professional liability
|
|
IBNR
|
Incurred but not reported
|
|
Inova Re
|
Inova Re, LTD, S.P.C.
|
|
IRS
|
Internal Revenue Service
|
|
LIBOR
|
London Interbank Offered Rate
|
|
LLC
|
Limited liability company
|
|
Lloyd's
|
Lloyd's of London market
|
|
LP
|
Limited partnership
|
|
Medical technology liability
|
Medical technology and life sciences products liability
|
|
NAV
|
Net asset value
|
|
NOL
|
Net operating loss
|
|
NRSRO
|
Nationally recognized statistical rating organization
|
|
NYSE
|
New York Stock Exchange
|
|
OCI
|
Other comprehensive income (loss)
|
|
OTTI
|
Other-than-temporary impairment
|
|
PCAOB
|
Public Company Accounting Oversight Board
|
|
Revolving Credit Agreement
|
ProAssurance's $250 million revolving credit agreement
|
|
ROE
|
Return on equity
|
|
SEC
|
Securities and Exchange Commission
|
|
SPA
|
Special Purpose Arrangement
|
|
SPC
|
Segregated portfolio cell
|
|
Specialty P&C
|
Specialty Property and Casualty
|
|
Syndicate 1729
|
Lloyd's of London Syndicate 1729
|
|
Syndicate 6131
|
Lloyd's of London Syndicate 6131, a Special Purpose Arrangement with Lloyd's of London Syndicate 1729
|
|
Syndicate Credit Agreement
|
Unconditional revolving credit agreement with the Premium Trust Fund of Syndicate 1729
|
|
TCJA
|
Tax Cuts and Jobs Act H.R.1 of 2017
|
|
Term
|
Meaning
|
|
U.K.
|
United Kingdom of Great Britain and Northern Ireland
|
|
VIE
|
Variable interest entity
|
|
|
changes in general economic conditions, including the impact of inflation or deflation and unemployment;
|
|
|
our ability to maintain our dividend payments;
|
|
|
regulatory, legislative and judicial actions or decisions that could affect our business plans or operations;
|
|
|
the enactment or repeal of tort reforms;
|
|
|
formation or dissolution of state-sponsored insurance entities providing coverages now offered by ProAssurance which could remove or add sizable numbers of insureds from or to the private insurance market;
|
|
|
changes in the interest and tax rate environment;
|
|
|
resolution of uncertain tax matters and changes in tax laws, including the impact of the TCJA;
|
|
|
changes in U.S. laws or government regulations regarding financial markets or market activity that may affect the U.S. economy and our business;
|
|
|
changes in the ability of the U.S. government to meet its obligations that may affect the U.S. economy and our business;
|
|
|
performance of financial markets affecting the fair value of our investments or making it difficult to determine the value of our investments;
|
|
|
changes in requirements or accounting policies and practices that may be adopted by our regulatory agencies, the FASB, the SEC, the PCAOB or the NYSE that may affect our business;
|
|
|
changes in laws or government regulations affecting the financial services industry, the property and casualty insurance industry or particular insurance lines underwritten by our subsidiaries;
|
|
|
the effect on our insureds, particularly the insurance needs of our insureds, and our loss costs, of changes in the healthcare delivery system and/or changes in the U.S. political climate that may affect healthcare policy or our business;
|
|
|
consolidation of our insureds into or under larger entities which may be insured by competitors, or may not have a risk profile that meets our underwriting criteria or which may not use external providers for insuring or otherwise managing substantial portions of their liability risk;
|
|
|
uncertainties inherent in the estimate of our loss and loss adjustment expense reserve and reinsurance recoverable;
|
|
|
changes in the availability, cost, quality or collectability of insurance/reinsurance;
|
|
|
the results of litigation, including pre- or post-trial motions, trials and/or appeals we undertake;
|
|
|
effects on our claims costs from mass tort litigation that are different from that anticipated by us;
|
|
|
allegations of bad faith which may arise from our handling of any particular claim, including failure to settle;
|
|
|
loss or consolidation of independent agents, agencies, brokers or brokerage firms;
|
|
|
changes in our organization, compensation and benefit plans;
|
|
|
changes in the business or competitive environment may limit the effectiveness of our business strategy and impact our revenues;
|
|
|
our ability to retain and recruit senior management;
|
|
|
the availability, integrity and security of our technology infrastructure or that of our third-party providers of technology infrastructure, including any susceptibility to cyber-attacks which might result in a loss of information or operating capability;
|
|
|
the impact of a catastrophic event, as it relates to both our operations and our insured risks;
|
|
|
the impact of acts of terrorism and acts of war;
|
|
|
the effects of terrorism-related insurance legislation and laws;
|
|
|
guaranty funds and other state assessments;
|
|
|
our ability to achieve continued growth through expansion into new markets or through acquisitions or business combinations;
|
|
|
changes to the ratings assigned by rating agencies to our insurance subsidiaries, individually or as a group;
|
|
|
provisions in our charter documents, Delaware law and state insurance laws may impede attempts to replace or remove management or may impede a takeover;
|
|
|
state insurance restrictions may prohibit assets held by our insurance subsidiaries, including cash and investment securities, from being used for general corporate purposes;
|
|
|
taxing authorities can take exception to our tax positions and cause us to incur significant amounts of legal and accounting costs and, if our defense is not successful, additional tax costs, including interest and penalties; and
|
|
|
expected benefits from completed and proposed acquisitions may not be achieved or may be delayed longer than expected due to business disruption; loss of customers, employees or key agents; increased operating costs or inability to achieve cost savings; and assumption of greater than expected liabilities, among other reasons.
|
|
Additional risks, assumptions and uncertainties that could arise from our membership in the Lloyd's market and our participation in Lloyd's Syndicates include, but are not limited to, the following:
|
|
|
|
members of Lloyd's are subject to levies by the Council of Lloyd's based on a percentage of the member's underwriting capacity, currently a maximum of 3%, but can be increased by Lloyd's;
|
|
|
Syndicate operating results can be affected by decisions made by the Council of Lloyd's which the management of Syndicate 1729 and Syndicate 6131 have little ability to control, such as a decision to not approve the business plan of Syndicate 1729 or Syndicate 6131, or a decision to increase the capital required to continue operations, and by our obligation to pay levies to Lloyd's;
|
|
|
Lloyd's insurance and reinsurance relationships and distribution channels could be disrupted or Lloyd's trading licenses could be revoked making it more difficult for a Lloyd's Syndicate to distribute and market its products;
|
|
|
rating agencies could downgrade their ratings of Lloyd's as a whole; and
|
|
|
Syndicate 1729 and Syndicate 6131 operations are dependent on a small, specialized management team and the loss of their services could adversely affect the Syndicate’s business. The inability to identify, hire and retain other highly qualified personnel in the future, could adversely affect the quality and profitability of Syndicate 1729’s or Syndicate 6131's business.
|
|
|
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
||
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Assets
|
|
|
|
||||
|
Investments
|
|
|
|
||||
|
Fixed maturities, at fair value; cost or amortized cost, $2,169,546 and $2,257,188, respectively
|
$
|
2,157,831
|
|
|
$
|
2,280,242
|
|
|
Equity investments, at fair value; cost, $471,337 and $425,942, respectively
|
492,159
|
|
|
470,609
|
|
||
|
Short-term investments
|
349,119
|
|
|
432,126
|
|
||
|
Business owned life insurance
|
62,562
|
|
|
62,113
|
|
||
|
Investment in unconsolidated subsidiaries
|
401,030
|
|
|
330,591
|
|
||
|
Other investments, $33,042 and $52,301 at fair value, respectively, otherwise at cost or amortized cost
|
35,944
|
|
|
110,847
|
|
||
|
Total Investments
|
3,498,645
|
|
|
3,686,528
|
|
||
|
Cash and cash equivalents
|
43,247
|
|
|
134,495
|
|
||
|
Premiums receivable
|
247,644
|
|
|
238,085
|
|
||
|
Receivable from reinsurers on paid losses and loss adjustment expenses
|
12,935
|
|
|
7,317
|
|
||
|
Receivable from reinsurers on unpaid losses and loss adjustment expenses
|
329,540
|
|
|
335,585
|
|
||
|
Prepaid reinsurance premiums
|
39,899
|
|
|
39,916
|
|
||
|
Deferred policy acquisition costs
|
50,765
|
|
|
50,261
|
|
||
|
Deferred tax asset, net
|
16,874
|
|
|
9,930
|
|
||
|
Real estate, net
|
31,646
|
|
|
31,975
|
|
||
|
Intangible assets, net
|
81,408
|
|
|
82,952
|
|
||
|
Goodwill
|
210,725
|
|
|
210,725
|
|
||
|
Other assets
|
115,596
|
|
|
101,428
|
|
||
|
Total Assets
|
$
|
4,678,924
|
|
|
$
|
4,929,197
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
||||
|
Liabilities
|
|
|
|
||||
|
Policy liabilities and accruals
|
|
|
|
||||
|
Reserve for losses and loss adjustment expenses
|
$
|
2,056,801
|
|
|
$
|
2,048,381
|
|
|
Unearned premiums
|
426,627
|
|
|
398,884
|
|
||
|
Reinsurance premiums payable
|
46,933
|
|
|
37,726
|
|
||
|
Total Policy Liabilities
|
2,530,361
|
|
|
2,484,991
|
|
||
|
Other liabilities
|
207,866
|
|
|
437,600
|
|
||
|
Debt less debt issuance costs
|
371,528
|
|
|
411,811
|
|
||
|
Total Liabilities
|
3,109,755
|
|
|
3,334,402
|
|
||
|
Shareholders' Equity
|
|
|
|
||||
|
Common shares, par value $0.01 per share, 100,000,000 shares authorized, 62,960,615 and 62,824,523 shares issued, respectively
|
630
|
|
|
628
|
|
||
|
Additional paid-in capital
|
380,250
|
|
|
383,077
|
|
||
|
Accumulated other comprehensive income (loss), net of deferred tax expense (benefit) of ($1,842) and $5,218, respectively
|
(8,046
|
)
|
|
14,911
|
|
||
|
Retained earnings
|
1,614,344
|
|
|
1,614,186
|
|
||
|
Treasury shares, at cost, 9,367,545 shares and 9,367,502 shares, respectively
|
(418,009
|
)
|
|
(418,007
|
)
|
||
|
Total Shareholders' Equity
|
1,569,169
|
|
|
1,594,795
|
|
||
|
Total Liabilities and Shareholders' Equity
|
$
|
4,678,924
|
|
|
$
|
4,929,197
|
|
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
|
Balance at December 31, 2017
|
|
$
|
628
|
|
|
$
|
383,077
|
|
|
$
|
14,911
|
|
|
$
|
1,614,186
|
|
|
$
|
(418,007
|
)
|
|
$
|
1,594,795
|
|
|
Cumulative-effect adjustment-
ASU 2016-01 adoption* |
|
—
|
|
|
—
|
|
|
—
|
|
|
8,334
|
|
|
—
|
|
|
8,334
|
|
||||||
|
Cumulative-effect adjustment-
ASU 2018-02 adoption* |
|
—
|
|
|
—
|
|
|
3,416
|
|
|
(3,416
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
122
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
120
|
|
||||||
|
Share-based compensation
|
|
—
|
|
|
902
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
902
|
|
||||||
|
Net effect of restricted and performance shares issued
|
|
2
|
|
|
(3,851
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,849
|
)
|
||||||
|
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,616
|
)
|
|
—
|
|
|
(16,616
|
)
|
||||||
|
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
(26,373
|
)
|
|
—
|
|
|
—
|
|
|
(26,373
|
)
|
||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,856
|
|
|
—
|
|
|
11,856
|
|
||||||
|
Balance at March 31, 2018
|
|
$
|
630
|
|
|
$
|
380,250
|
|
|
$
|
(8,046
|
)
|
|
$
|
1,614,344
|
|
|
$
|
(418,009
|
)
|
|
$
|
1,569,169
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Total
|
||||||||||||
|
Balance at December 31, 2016
|
|
$
|
627
|
|
|
$
|
376,518
|
|
|
$
|
17,399
|
|
|
$
|
1,824,088
|
|
|
$
|
(419,930
|
)
|
|
$
|
1,798,702
|
|
|
Cumulative-effect adjustment-
ASU 2016-09 adoption |
|
—
|
|
|
425
|
|
|
—
|
|
|
(276
|
)
|
|
—
|
|
|
149
|
|
||||||
|
Common shares issued for compensation and effect of shares reissued to stock purchase plan
|
|
—
|
|
|
938
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
940
|
|
||||||
|
Share-based compensation
|
|
—
|
|
|
3,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,346
|
|
||||||
|
Net effect of restricted and performance shares issued
|
|
1
|
|
|
(5,315
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,314
|
)
|
||||||
|
Dividends to shareholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(16,516
|
)
|
|
—
|
|
|
(16,516
|
)
|
||||||
|
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
2,924
|
|
|
—
|
|
|
—
|
|
|
2,924
|
|
||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
41,455
|
|
|
—
|
|
|
41,455
|
|
||||||
|
Balance at March 31, 2017
|
|
$
|
628
|
|
|
$
|
375,912
|
|
|
$
|
20,323
|
|
|
$
|
1,848,751
|
|
|
$
|
(419,928
|
)
|
|
$
|
1,825,686
|
|
|
* See Note 1 for discussion of accounting guidance adopted during the period.
|
||||||||||||||||||||||||
|
|
|
Three Months Ended March 31
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Revenues
|
|
|
|
|
||||
|
Net premiums earned
|
|
$
|
187,159
|
|
|
$
|
182,903
|
|
|
Net investment income
|
|
22,027
|
|
|
23,186
|
|
||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
|
1,640
|
|
|
1,808
|
|
||
|
Net realized investment gains (losses):
|
|
|
|
|
||||
|
OTTI losses
|
|
—
|
|
|
(419
|
)
|
||
|
Portion of OTTI losses recognized in other comprehensive income before taxes
|
|
—
|
|
|
248
|
|
||
|
Net impairment losses recognized in earnings
|
|
—
|
|
|
(171
|
)
|
||
|
Other net realized investment gains (losses)
|
|
(12,517
|
)
|
|
13,451
|
|
||
|
Total net realized investment gains (losses)
|
|
(12,517
|
)
|
|
13,280
|
|
||
|
Other income
|
|
2,723
|
|
|
1,821
|
|
||
|
Total revenues
|
|
201,032
|
|
|
222,998
|
|
||
|
Expenses
|
|
|
|
|
||||
|
Net losses and loss adjustment expenses
|
|
129,786
|
|
|
119,151
|
|
||
|
Underwriting, policy acquisition and operating expenses
|
|
|
|
|
||||
|
Operating expense
|
|
32,467
|
|
|
34,482
|
|
||
|
DPAC amortization
|
|
24,893
|
|
|
22,626
|
|
||
|
Segregated portfolio cells dividend expense (income)
|
|
1,747
|
|
|
2,375
|
|
||
|
Interest expense
|
|
3,705
|
|
|
4,133
|
|
||
|
Total expenses
|
|
192,598
|
|
|
182,767
|
|
||
|
Income before income taxes
|
|
8,434
|
|
|
40,231
|
|
||
|
Provision for income taxes
|
|
|
|
|
||||
|
Current expense (benefit)
|
|
(1,328
|
)
|
|
(8,278
|
)
|
||
|
Deferred expense (benefit)
|
|
(2,094
|
)
|
|
7,054
|
|
||
|
Total income tax expense (benefit)
|
|
(3,422
|
)
|
|
(1,224
|
)
|
||
|
Net income
|
|
11,856
|
|
|
41,455
|
|
||
|
Other comprehensive income (loss), after tax, net of reclassification adjustments
|
|
(26,373
|
)
|
|
2,924
|
|
||
|
Comprehensive income (loss)
|
|
$
|
(14,517
|
)
|
|
$
|
44,379
|
|
|
Earnings per share
|
|
|
|
|
||||
|
Basic
|
|
$
|
0.22
|
|
|
$
|
0.78
|
|
|
Diluted
|
|
$
|
0.22
|
|
|
$
|
0.77
|
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
||||
|
Basic
|
|
53,515
|
|
|
53,315
|
|
||
|
Diluted
|
|
53,682
|
|
|
53,535
|
|
||
|
Cash dividends declared per common share
|
|
$
|
0.31
|
|
|
$
|
0.31
|
|
|
|
Three Months Ended March 31
|
||||||
|
|
2018
|
|
2017
|
||||
|
Operating Activities
|
|
|
|
||||
|
Net income
|
$
|
11,856
|
|
|
$
|
41,455
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization, net of accretion
|
6,079
|
|
|
7,803
|
|
||
|
(Increase) decrease in cash surrender value of BOLI
|
(449
|
)
|
|
(455
|
)
|
||
|
Net realized investment (gains) losses
|
12,517
|
|
|
(13,280
|
)
|
||
|
Share-based compensation
|
902
|
|
|
3,346
|
|
||
|
Deferred income taxes
|
(2,094
|
)
|
|
7,054
|
|
||
|
Policy acquisition costs, net of amortization (net deferral)
|
(504
|
)
|
|
(2,376
|
)
|
||
|
Equity in (earnings) loss of unconsolidated subsidiaries
|
(1,640
|
)
|
|
(1,808
|
)
|
||
|
Distributed earnings from unconsolidated subsidiaries
|
7,018
|
|
|
10,893
|
|
||
|
Other
|
752
|
|
|
(167
|
)
|
||
|
Other changes in assets and liabilities:
|
|
|
|
||||
|
Premiums receivable
|
(9,559
|
)
|
|
(1,238
|
)
|
||
|
Reinsurance related assets and liabilities
|
9,651
|
|
|
2,428
|
|
||
|
Other assets
|
6,254
|
|
|
(5,027
|
)
|
||
|
Reserve for losses and loss adjustment expenses
|
8,420
|
|
|
3,561
|
|
||
|
Unearned premiums
|
27,743
|
|
|
24,576
|
|
||
|
Other liabilities
|
(3,592
|
)
|
|
(7,393
|
)
|
||
|
Net cash provided (used) by operating activities
|
73,354
|
|
|
69,372
|
|
||
|
Investing Activities
|
|
|
|
||||
|
Purchases of:
|
|
|
|
||||
|
Fixed maturities, available for sale
|
(367,872
|
)
|
|
(160,364
|
)
|
||
|
Fixed maturities, trading
|
(4,162
|
)
|
|
—
|
|
||
|
Equity investments
|
(67,129
|
)
|
|
(35,400
|
)
|
||
|
Other investments
|
(7,108
|
)
|
|
(3,930
|
)
|
||
|
Funding of qualified affordable housing project tax credit partnerships
|
—
|
|
|
(37
|
)
|
||
|
Investment in unconsolidated subsidiaries
|
(21,985
|
)
|
|
(5,613
|
)
|
||
|
Proceeds from sales or maturities of:
|
|
|
|
||||
|
Fixed maturities, available for sale
|
459,822
|
|
|
171,986
|
|
||
|
Equity investments
|
51,085
|
|
|
41,584
|
|
||
|
Other investments
|
6,092
|
|
|
6,788
|
|
||
|
Return of invested capital from unconsolidated subsidiaries
|
11,783
|
|
|
6,955
|
|
||
|
Net sales or maturities (purchases) of short-term investments
|
82,976
|
|
|
160,792
|
|
||
|
Unsettled security transactions, net change
|
22,421
|
|
|
6,296
|
|
||
|
Purchases of capital assets
|
(1,836
|
)
|
|
(4,535
|
)
|
||
|
Repayments (advances) under Syndicate Credit Agreement
|
(17,980
|
)
|
|
1,159
|
|
||
|
Net cash provided (used) by investing activities
|
146,107
|
|
|
185,681
|
|
||
|
Continued on the following page.
|
|
|
|
||||
|
|
Three Months Ended March 31
|
||||||
|
|
2018
|
|
2017
|
||||
|
Continued from the previous page.
|
|
|
|
||||
|
Financing Activities
|
|
|
|
||||
|
Borrowings (repayments) under Revolving Credit Agreement
|
(40,000
|
)
|
|
—
|
|
||
|
Repayments of Mortgage Loans
|
(349
|
)
|
|
—
|
|
||
|
Dividends to shareholders
|
(266,734
|
)
|
|
(265,664
|
)
|
||
|
External capital contribution received for segregated portfolio cells
|
251
|
|
|
114
|
|
||
|
Other
|
(3,877
|
)
|
|
(4,932
|
)
|
||
|
Net cash provided (used) by financing activities
|
(310,709
|
)
|
|
(270,482
|
)
|
||
|
Increase (decrease) in cash and cash equivalents
|
(91,248
|
)
|
|
(15,429
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
134,495
|
|
|
117,347
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
43,247
|
|
|
$
|
101,918
|
|
|
Significant Non-Cash Transactions
|
|
|
|
||||
|
Dividends declared and not yet paid
|
$
|
16,616
|
|
|
$
|
16,516
|
|
|
(In thousands)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
SPC dividends payable
|
|
$
|
47,122
|
|
|
$
|
46,925
|
|
|
Unpaid dividends
|
|
16,616
|
|
|
267,292
|
|
||
|
All other
|
|
144,128
|
|
|
123,383
|
|
||
|
Total other liabilities
|
|
$
|
207,866
|
|
|
$
|
437,600
|
|
|
|
Level 1:
|
quoted (unadjusted) market prices in active markets for identical assets and liabilities. For ProAssurance, Level 1 inputs are generally quotes for debt or equity securities actively traded in exchange or over-the-counter markets.
|
|
|
Level 2:
|
market data obtained from sources independent of the reporting entity (observable inputs). For ProAssurance, Level 2 inputs generally include quoted prices in markets that are not active, quoted prices for similar assets or liabilities, and results from pricing models that use observable inputs such as interest rates and yield curves that are generally available at commonly quoted intervals.
|
|
|
Level 3:
|
the reporting entity's own assumptions about market participant assumptions based on the best information available in the circumstances (non-observable inputs). For ProAssurance, Level 3 inputs are used in situations where little or no Level 1 or 2 inputs are available or are inappropriate given the particular circumstances. Level 3 inputs include results from pricing models for which some or all of the inputs are not observable, discounted cash flow methodologies, single non-binding broker quotes and adjustments to externally quoted prices that are based on management judgment or estimation.
|
|
|
March 31, 2018
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
129,751
|
|
|
$
|
—
|
|
|
$
|
129,751
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
29,959
|
|
|
—
|
|
|
29,959
|
|
||||
|
State and municipal bonds
|
—
|
|
|
329,995
|
|
|
—
|
|
|
329,995
|
|
||||
|
Corporate debt, multiple observable inputs
|
2,334
|
|
|
1,230,832
|
|
|
—
|
|
|
1,233,166
|
|
||||
|
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
15,097
|
|
|
15,097
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
215,420
|
|
|
—
|
|
|
215,420
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
14,887
|
|
|
—
|
|
|
14,887
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
29,195
|
|
|
—
|
|
|
29,195
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
138,890
|
|
|
17,323
|
|
|
156,213
|
|
||||
|
Fixed maturities, trading
|
|
|
|
|
|
|
|
|
|||||||
|
Corporate debt
|
—
|
|
|
4,148
|
|
|
—
|
|
|
4,148
|
|
||||
|
Equity investments
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
74,556
|
|
|
—
|
|
|
—
|
|
|
74,556
|
|
||||
|
Utilities/Energy
|
46,637
|
|
|
—
|
|
|
—
|
|
|
46,637
|
|
||||
|
Consumer oriented
|
54,789
|
|
|
—
|
|
|
—
|
|
|
54,789
|
|
||||
|
Industrial
|
48,859
|
|
|
—
|
|
|
—
|
|
|
48,859
|
|
||||
|
Bond funds
|
153,256
|
|
|
—
|
|
|
—
|
|
|
153,256
|
|
||||
|
All other
|
93,847
|
|
|
—
|
|
|
—
|
|
|
93,847
|
|
||||
|
Short-term investments
|
288,019
|
|
|
61,100
|
|
|
—
|
|
|
349,119
|
|
||||
|
Other investments
|
604
|
|
|
32,073
|
|
|
365
|
|
|
33,042
|
|
||||
|
Other assets
|
—
|
|
|
2,306
|
|
|
—
|
|
|
2,306
|
|
||||
|
Total assets categorized within the fair value hierarchy
|
$
|
762,901
|
|
|
$
|
2,218,556
|
|
|
$
|
32,785
|
|
|
3,014,242
|
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Equity investments
|
|
|
|
|
|
|
20,215
|
|
|||||||
|
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
277,094
|
|
|||||||
|
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,311,551
|
|
||||||
|
|
December 31, 2017
|
||||||||||||||
|
|
Fair Value Measurements Using
|
|
Total
|
||||||||||||
|
(In thousands)
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
—
|
|
|
$
|
133,627
|
|
|
$
|
—
|
|
|
$
|
133,627
|
|
|
U.S. Government-sponsored enterprise obligations
|
—
|
|
|
20,956
|
|
|
—
|
|
|
20,956
|
|
||||
|
State and municipal bonds
|
—
|
|
|
632,243
|
|
|
—
|
|
|
632,243
|
|
||||
|
Corporate debt, multiple observable inputs
|
2,371
|
|
|
1,151,084
|
|
|
—
|
|
|
1,153,455
|
|
||||
|
Corporate debt, limited observable inputs
|
—
|
|
|
—
|
|
|
13,703
|
|
|
13,703
|
|
||||
|
Residential mortgage-backed securities
|
—
|
|
|
196,789
|
|
|
1,055
|
|
|
197,844
|
|
||||
|
Agency commercial mortgage-backed securities
|
—
|
|
|
10,742
|
|
|
—
|
|
|
10,742
|
|
||||
|
Other commercial mortgage-backed securities
|
—
|
|
|
15,961
|
|
|
—
|
|
|
15,961
|
|
||||
|
Other asset-backed securities
|
—
|
|
|
97,780
|
|
|
3,931
|
|
|
101,711
|
|
||||
|
Equity investments
|
|
|
|
|
|
|
|
||||||||
|
Financial
|
76,051
|
|
|
—
|
|
|
—
|
|
|
76,051
|
|
||||
|
Utilities/Energy
|
54,388
|
|
|
—
|
|
|
—
|
|
|
54,388
|
|
||||
|
Consumer oriented
|
54,529
|
|
|
—
|
|
|
—
|
|
|
54,529
|
|
||||
|
Industrial
|
53,936
|
|
|
—
|
|
|
—
|
|
|
53,936
|
|
||||
|
Bond funds
|
156,563
|
|
|
—
|
|
|
—
|
|
|
156,563
|
|
||||
|
All other
|
75,142
|
|
|
—
|
|
|
—
|
|
|
75,142
|
|
||||
|
Short-term investments
|
404,204
|
|
|
27,922
|
|
|
—
|
|
|
432,126
|
|
||||
|
Other investments
|
607
|
|
|
31,155
|
|
|
409
|
|
|
32,171
|
|
||||
|
Other assets
|
—
|
|
|
1,731
|
|
|
—
|
|
|
1,731
|
|
||||
|
Total assets categorized within the fair value hierarchy
|
$
|
877,791
|
|
|
$
|
2,319,990
|
|
|
$
|
19,098
|
|
|
3,216,879
|
|
|
|
Assets carried at NAV, which approximates fair value and which are not categorized within the fair value hierarchy, reported as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Investment in unconsolidated subsidiaries
|
|
|
|
|
|
|
210,759
|
|
|||||||
|
Other investments
|
|
|
|
|
|
|
20,130
|
|
|||||||
|
Total assets at fair value
|
|
|
|
|
|
|
$
|
3,447,768
|
|
||||||
|
•
|
Level 3 securities are priced by the Chief Investment Officer.
|
|
•
|
Level 3 valuations are computed quarterly. Prices are evaluated quarterly against prior period prices and the expected change in prices.
|
|
•
|
ProAssurance's Level 3 securities are primarily
NRSRO
rated debt instruments for which comparable market inputs are commonly available for evaluating the securities in question. Valuation of these debt instruments is not overly sensitive to changes in the unobservable inputs used.
|
|
|
|
Fair Value at
|
|
|
|
|
|
|
||
|
(In thousands)
|
|
March 31, 2018
|
|
December 31, 2017
|
|
Valuation Technique
|
|
Unobservable Input
|
|
Range
(Weighted Average) |
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt, limited observable inputs
|
|
$15,097
|
|
$13,703
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
Residential mortgage-backed and other asset-backed securities
|
|
$17,323
|
|
$4,986
|
|
Market Comparable
Securities |
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
|
|
|
|
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 5% (2.5%)
|
|
Other investments
|
|
$365
|
|
$409
|
|
Discounted Cash Flows
|
|
Comparability Adjustment
|
|
0% - 10% (5%)
|
|
|
March 31, 2018
|
||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
|
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
|
Balance December 31, 2017
|
$
|
13,703
|
|
|
$
|
4,986
|
|
|
$
|
409
|
|
|
$
|
19,098
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Net investment income
|
(38
|
)
|
|
—
|
|
|
—
|
|
|
(38
|
)
|
||||
|
Net realized investment gains (losses)
|
—
|
|
|
—
|
|
|
(44
|
)
|
|
(44
|
)
|
||||
|
Included in other comprehensive income
|
(38
|
)
|
|
(30
|
)
|
|
—
|
|
|
(68
|
)
|
||||
|
Purchases
|
6,005
|
|
|
13,453
|
|
|
—
|
|
|
19,458
|
|
||||
|
Sales
|
(2,905
|
)
|
|
(27
|
)
|
|
—
|
|
|
(2,932
|
)
|
||||
|
Transfers in
|
2,069
|
|
|
—
|
|
|
—
|
|
|
2,069
|
|
||||
|
Transfers out
|
(3,699
|
)
|
|
(1,059
|
)
|
|
—
|
|
|
(4,758
|
)
|
||||
|
Balance March 31, 2018
|
$
|
15,097
|
|
|
$
|
17,323
|
|
|
$
|
365
|
|
|
$
|
32,785
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
March 31, 2017
|
||||||||||||||
|
|
Level 3 Fair Value Measurements – Assets
|
||||||||||||||
|
(In thousands)
|
Corporate Debt
|
|
Asset-backed Securities
|
|
Other investments
|
|
Total
|
||||||||
|
Balance December 31, 2016
|
$
|
14,810
|
|
|
$
|
3,007
|
|
|
$
|
3
|
|
|
$
|
17,820
|
|
|
Total gains (losses) realized and unrealized:
|
|
|
|
|
|
|
|
||||||||
|
Included in earnings, as a part of:
|
|
|
|
|
|
|
|
||||||||
|
Net investment income
|
(39
|
)
|
|
—
|
|
|
—
|
|
|
(39
|
)
|
||||
|
Net realized investment gains (losses)
|
13
|
|
|
—
|
|
|
—
|
|
|
13
|
|
||||
|
Included in other comprehensive income
|
(208
|
)
|
|
(5
|
)
|
|
2
|
|
|
(211
|
)
|
||||
|
Purchases
|
7,048
|
|
|
—
|
|
|
—
|
|
|
7,048
|
|
||||
|
Sales
|
(1,712
|
)
|
|
—
|
|
|
—
|
|
|
(1,712
|
)
|
||||
|
Transfers in
|
—
|
|
|
—
|
|
|
898
|
|
|
898
|
|
||||
|
Transfers out
|
(998
|
)
|
|
—
|
|
|
—
|
|
|
(998
|
)
|
||||
|
Balance March 31, 2017
|
$
|
18,914
|
|
|
$
|
3,002
|
|
|
$
|
903
|
|
|
$
|
22,819
|
|
|
Change in unrealized gains (losses) included in earnings for the above period for Level 3 assets held at period-end
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Unfunded
Commitments |
|
Fair Value
|
||||||
|
(In thousands)
|
March 31,
2018 |
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Equity investments:
|
|
|
|
|
|
||||
|
Mortgage fund
(1)*
|
None
|
|
$
|
20,215
|
|
|
$
|
—
|
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
|
|
||||
|
Private debt funds
(2)
|
$4,976
|
|
32,064
|
|
|
42,206
|
|
||
|
Long equity fund
(3)
|
None
|
|
7,957
|
|
|
7,847
|
|
||
|
Long/short equity funds
(4)
|
None
|
|
32,177
|
|
|
31,352
|
|
||
|
Non-public equity funds
(5)
|
$82,135
|
|
105,049
|
|
|
100,062
|
|
||
|
Multi-strategy fund of funds
(6)
|
None
|
|
9,274
|
|
|
9,100
|
|
||
|
Credit funds
(7)
|
None
|
|
17,789
|
|
|
6,561
|
|
||
|
Long/short commodities fund
(8)
|
None
|
|
13,063
|
|
|
13,025
|
|
||
|
Strategy focused funds
(9)
|
$19,241
|
|
59,721
|
|
|
606
|
|
||
|
|
|
|
277,094
|
|
|
210,759
|
|
||
|
Other investments:
|
|
|
|
|
|
||||
|
Mortgage fund
(1)*
|
See above
|
|
—
|
|
|
20,130
|
|
||
|
|
|
|
|
|
|
||||
|
Total investments carried at NAV
|
|
|
$
|
297,309
|
|
|
$
|
230,889
|
|
|
* In the first quarter of 2018, ProAssurance began presenting this investment previously reported as a part of other investments as a part of equity investments on the Condensed Consolidated Balance Sheet as of March 31, 2018. Prior year amounts have not been reclassified.
|
|||||||||
|
(1)
|
This investment fund is focused on the structured mortgage market. The fund will primarily invest in U.S. Agency mortgage-backed securities. Redemptions are allowed at the end of any calendar quarter with a prior notice requirement of
65 days
and are paid within
45 days
at the end of the redemption dealing day.
|
|
(2)
|
The investment is comprised of interests in two unrelated
LP
funds that are structured to provide interest distributions primarily through diversified portfolios of private debt instruments. One
LP
allows redemption by special consent; the other does not permit redemption. Income and capital are to be periodically distributed at the discretion of the
LP
s over an anticipated time frame that spans from
three
to
eight
years.
|
|
(3)
|
The fund is a
LP
that holds long equities of public international companies. Redemptions are allowed at the end of any calendar month with a prior notice requirement of
15 days
and are paid within
10 days
of the end of the calendar month of the redemption request.
|
|
(4)
|
The investment is comprised of interests in multiple unrelated
LP
funds. The funds hold primarily long and short North American equities and target absolute returns using strategies designed to take advantage of market opportunities. The funds generally permit quarterly or semi-annual capital redemptions subject to notice requirements of
30
to
90 days
. For some funds, redemptions above specified thresholds (lowest threshold is
90%
) may be only partially payable until after a fund audit is completed and are then payable within
30 days
.
|
|
(5)
|
The investment is comprised of interests in multiple unrelated
LP
funds, each structured to provide capital appreciation through diversified investments in private equity, which can include investments in buyout, venture capital, debt including senior, second lien and mezzanine, distressed debt and other private equity-oriented
LP
s. Two of the
LP
s allow redemption by terms set forth in the
LP
agreements; the others do not permit redemption. Income and capital are to be periodically distributed at the discretion of the
LP
over time frames that are anticipated to span up to
nine
years.
|
|
(6)
|
This fund is a
LLC
structured to build and manage low volatility, multi-manager portfolios that have little or no correlation to the broader fixed income and equity security markets. Redemptions are not permitted but offers to repurchase units of the
LLC
may be extended periodically.
|
|
(7)
|
The investment is comprised of two unrelated
LP
funds. One fund seeks to obtain superior risk-adjusted absolute returns through a diversified portfolio of debt securities, including bonds, loans and other asset-backed instruments. The second fund seeks event driven opportunities across the corporate credit spectrum. For both funds, redemptions are allowed at any quarter-end with a prior notice requirement of
90 days
.
|
|
(8)
|
This fund is a
LLC
invested across a broad range of commodities and focuses primarily on market neutral, relative value strategies, seeking to generate absolute returns with low correlation to broad commodity, equity and fixed income markets. Following an initial one-year lock-up period, redemptions are allowed with a prior notice requirement of
30 days
and are payable within
30 days
.
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
(In thousands)
|
Carrying
Value |
|
Fair
Value |
|
Carrying
Value |
|
Fair
Value |
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
||||||||
|
BOLI
|
$
|
62,562
|
|
|
$
|
62,562
|
|
|
$
|
62,113
|
|
|
$
|
62,113
|
|
|
Other investments
|
$
|
2,902
|
|
|
$
|
2,902
|
|
|
$
|
58,546
|
|
|
$
|
69,095
|
|
|
Other assets
|
$
|
49,549
|
|
|
$
|
48,816
|
|
|
$
|
34,020
|
|
|
$
|
33,742
|
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Senior notes due 2023*
|
$
|
250,000
|
|
|
$
|
269,418
|
|
|
$
|
250,000
|
|
|
$
|
273,153
|
|
|
Revolving Credit Agreement*
|
$
|
83,000
|
|
|
$
|
83,000
|
|
|
$
|
123,000
|
|
|
$
|
123,000
|
|
|
Mortgage loans*
|
$
|
40,111
|
|
|
$
|
40,111
|
|
|
$
|
40,460
|
|
|
$
|
40,460
|
|
|
Other liabilities
|
$
|
21,525
|
|
|
$
|
21,525
|
|
|
$
|
21,154
|
|
|
$
|
21,154
|
|
|
* Carrying value excludes debt issuance costs.
|
|||||||||||||||
|
|
March 31, 2018
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
131,655
|
|
|
$
|
305
|
|
|
$
|
2,209
|
|
|
$
|
129,751
|
|
|
U.S. Government-sponsored enterprise obligations
|
30,377
|
|
|
27
|
|
|
445
|
|
|
29,959
|
|
||||
|
State and municipal bonds
|
324,336
|
|
|
6,613
|
|
|
954
|
|
|
329,995
|
|
||||
|
Corporate debt
|
1,259,132
|
|
|
7,008
|
|
|
17,877
|
|
|
1,248,263
|
|
||||
|
Residential mortgage-backed securities
|
217,891
|
|
|
1,502
|
|
|
3,973
|
|
|
215,420
|
|
||||
|
Agency commercial mortgage-backed securities
|
15,078
|
|
|
29
|
|
|
220
|
|
|
14,887
|
|
||||
|
Other commercial mortgage-backed securities
|
29,409
|
|
|
100
|
|
|
314
|
|
|
29,195
|
|
||||
|
Other asset-backed securities
|
157,506
|
|
|
40
|
|
|
1,333
|
|
|
156,213
|
|
||||
|
|
$
|
2,165,384
|
|
|
$
|
15,624
|
|
|
$
|
27,325
|
|
|
$
|
2,153,683
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2017
|
||||||||||||||
|
(In thousands)
|
Amortized
Cost |
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Estimated Fair Value
|
||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
||||||||
|
U.S. Treasury obligations
|
$
|
134,323
|
|
|
$
|
485
|
|
|
$
|
1,181
|
|
|
$
|
133,627
|
|
|
U.S. Government-sponsored enterprise obligations
|
21,089
|
|
|
73
|
|
|
206
|
|
|
20,956
|
|
||||
|
State and municipal bonds
|
618,414
|
|
|
14,248
|
|
|
419
|
|
|
632,243
|
|
||||
|
Corporate debt
|
1,157,660
|
|
|
15,205
|
|
|
5,707
|
|
|
1,167,158
|
|
||||
|
Residential mortgage-backed securities
|
196,741
|
|
|
2,438
|
|
|
1,335
|
|
|
197,844
|
|
||||
|
Agency commercial mortgage-backed securities
|
10,827
|
|
|
23
|
|
|
108
|
|
|
10,742
|
|
||||
|
Other commercial mortgage-backed securities
|
16,004
|
|
|
91
|
|
|
134
|
|
|
15,961
|
|
||||
|
Other asset-backed securities
|
102,130
|
|
|
47
|
|
|
466
|
|
|
101,711
|
|
||||
|
|
$
|
2,257,188
|
|
|
$
|
32,610
|
|
|
$
|
9,556
|
|
|
$
|
2,280,242
|
|
|
(In thousands)
|
Amortized
Cost |
|
Due in one
year or less |
|
Due after
one year through five years |
|
Due after
five years through ten years |
|
Due after
ten years |
|
Total Fair
Value |
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
131,655
|
|
|
$
|
31,700
|
|
|
$
|
73,858
|
|
|
$
|
21,321
|
|
|
$
|
2,872
|
|
|
$
|
129,751
|
|
|
U.S. Government-sponsored enterprise obligations
|
30,377
|
|
|
—
|
|
|
8,009
|
|
|
21,814
|
|
|
136
|
|
|
29,959
|
|
||||||
|
State and municipal bonds
|
324,336
|
|
|
29,481
|
|
|
111,512
|
|
|
140,004
|
|
|
48,998
|
|
|
329,995
|
|
||||||
|
Corporate debt
|
1,259,132
|
|
|
115,385
|
|
|
682,646
|
|
|
404,159
|
|
|
46,073
|
|
|
1,248,263
|
|
||||||
|
Residential mortgage-backed securities
|
217,891
|
|
|
|
|
|
|
|
|
|
|
215,420
|
|
||||||||||
|
Agency commercial mortgage-backed securities
|
15,078
|
|
|
|
|
|
|
|
|
|
|
14,887
|
|
||||||||||
|
Other commercial mortgage-backed securities
|
29,409
|
|
|
|
|
|
|
|
|
|
|
29,195
|
|
||||||||||
|
Other asset-backed securities
|
157,506
|
|
|
|
|
|
|
|
|
|
|
156,213
|
|
||||||||||
|
|
$
|
2,165,384
|
|
|
|
|
|
|
|
|
|
|
$
|
2,153,683
|
|
||||||||
|
|
March 31, 2018
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
121,718
|
|
|
$
|
2,209
|
|
|
$
|
87,740
|
|
|
$
|
1,438
|
|
|
$
|
33,978
|
|
|
$
|
771
|
|
|
U.S. Government-sponsored enterprise obligations
|
29,018
|
|
|
445
|
|
|
22,252
|
|
|
218
|
|
|
6,766
|
|
|
227
|
|
||||||
|
State and municipal bonds
|
63,690
|
|
|
954
|
|
|
55,761
|
|
|
620
|
|
|
7,929
|
|
|
334
|
|
||||||
|
Corporate debt
|
848,499
|
|
|
17,877
|
|
|
733,344
|
|
|
13,216
|
|
|
115,155
|
|
|
4,661
|
|
||||||
|
Residential mortgage-backed securities
|
175,295
|
|
|
3,973
|
|
|
132,075
|
|
|
2,066
|
|
|
43,220
|
|
|
1,907
|
|
||||||
|
Agency commercial mortgage-backed securities
|
9,547
|
|
|
220
|
|
|
7,638
|
|
|
101
|
|
|
1,909
|
|
|
119
|
|
||||||
|
Other commercial mortgage-backed securities
|
19,145
|
|
|
314
|
|
|
15,723
|
|
|
256
|
|
|
3,422
|
|
|
58
|
|
||||||
|
Other asset-backed securities
|
118,780
|
|
|
1,333
|
|
|
105,370
|
|
|
1,134
|
|
|
13,410
|
|
|
199
|
|
||||||
|
|
$
|
1,385,692
|
|
|
$
|
27,325
|
|
|
$
|
1,159,903
|
|
|
$
|
19,049
|
|
|
$
|
225,789
|
|
|
$
|
8,276
|
|
|
|
December 31, 2017
|
||||||||||||||||||||||
|
|
Total
|
|
Less than 12 months
|
|
12 months or longer
|
||||||||||||||||||
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
|
Fair
|
|
Unrealized
|
||||||||||||
|
(In thousands)
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
|
Value
|
|
Loss
|
||||||||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
U.S. Treasury obligations
|
$
|
110,788
|
|
|
$
|
1,181
|
|
|
$
|
67,135
|
|
|
$
|
554
|
|
|
$
|
43,653
|
|
|
$
|
627
|
|
|
U.S. Government-sponsored enterprise obligations
|
17,032
|
|
|
206
|
|
|
10,182
|
|
|
64
|
|
|
6,850
|
|
|
142
|
|
||||||
|
State and municipal bonds
|
23,122
|
|
|
419
|
|
|
15,168
|
|
|
102
|
|
|
7,954
|
|
|
317
|
|
||||||
|
Corporate debt
|
487,578
|
|
|
5,707
|
|
|
365,541
|
|
|
2,730
|
|
|
122,037
|
|
|
2,977
|
|
||||||
|
Residential mortgage-backed securities
|
109,659
|
|
|
1,335
|
|
|
64,121
|
|
|
402
|
|
|
45,538
|
|
|
933
|
|
||||||
|
Agency commercial mortgage-backed securities
|
4,423
|
|
|
108
|
|
|
2,458
|
|
|
34
|
|
|
1,965
|
|
|
74
|
|
||||||
|
Other commercial mortgage-backed securities
|
12,878
|
|
|
134
|
|
|
7,939
|
|
|
82
|
|
|
4,939
|
|
|
52
|
|
||||||
|
Other asset-backed securities
|
85,358
|
|
|
466
|
|
|
70,924
|
|
|
346
|
|
|
14,434
|
|
|
120
|
|
||||||
|
|
$
|
850,838
|
|
|
$
|
9,556
|
|
|
$
|
603,468
|
|
|
$
|
4,314
|
|
|
$
|
247,370
|
|
|
$
|
5,242
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In millions)
|
2018
|
|
2017
|
||||
|
Proceeds from sales (exclusive of maturities and paydowns)
|
$
|
379.2
|
|
|
$
|
79.2
|
|
|
Purchases
|
$
|
367.9
|
|
|
$
|
160.4
|
|
|
|
Three Months Ended
March 31 |
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Fixed maturities
|
$
|
17,080
|
|
|
$
|
20,121
|
|
|
Equities
|
4,867
|
|
|
3,644
|
|
||
|
Short-term investments, including Other
|
1,308
|
|
|
801
|
|
||
|
BOLI
|
449
|
|
|
455
|
|
||
|
Investment fees and expenses
|
(1,677
|
)
|
|
(1,835
|
)
|
||
|
Net investment income
|
$
|
22,027
|
|
|
$
|
23,186
|
|
|
|
March 31, 2018
|
|
Carrying Value
|
|||||||
|
(In thousands)
|
Percentage
Ownership |
|
March 31,
2018 |
|
December 31,
2017 |
|||||
|
Qualified affordable housing project tax credit partnerships
|
See below
|
|
$
|
80,507
|
|
|
$
|
84,607
|
|
|
|
Other tax credit partnerships
|
See below
|
|
5,735
|
|
|
6,118
|
|
|||
|
All other investments, primarily investment fund LPs/LLCs
|
See below
|
|
314,788
|
|
|
239,866
|
|
|||
|
|
|
|
$
|
401,030
|
|
|
$
|
330,591
|
|
|
|
|
Three Months Ended
March 31 |
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Total OTTI losses:
|
|
|
|
||||
|
Corporate debt
|
$
|
—
|
|
|
$
|
(419
|
)
|
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
||||
|
Corporate debt
|
—
|
|
|
248
|
|
||
|
Net impairment losses recognized in earnings
|
—
|
|
|
(171
|
)
|
||
|
Gross realized gains, available-for-sale fixed maturities
|
4,464
|
|
|
1,853
|
|
||
|
Gross realized (losses), available-for-sale fixed maturities
|
(2,047
|
)
|
|
(67
|
)
|
||
|
Net realized gains (losses), equity investments
|
9,219
|
|
|
6,562
|
|
||
|
Net realized gains (losses), other investments
|
688
|
|
|
1,172
|
|
||
|
Change in unrealized holding gains (losses), trading fixed maturities
|
(49
|
)
|
|
—
|
|
||
|
Change in unrealized holding gains (losses), equity investments
|
(23,845
|
)
|
|
3,616
|
|
||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value
|
(954
|
)
|
|
313
|
|
||
|
Other
|
7
|
|
|
2
|
|
||
|
Net realized investment gains (losses)
|
$
|
(12,517
|
)
|
|
$
|
13,280
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Balance beginning of period
|
$
|
1,313
|
|
|
$
|
1,158
|
|
|
Additional credit losses recognized during the period, related to securities for which:
|
|
|
|
||||
|
No OTTI has been previously recognized
|
—
|
|
|
171
|
|
||
|
Balance March 31
|
$
|
1,313
|
|
|
$
|
1,329
|
|
|
(In thousands)
|
Three Months Ended March 31, 2018
|
|
Three Months Ended March 31, 2017
|
|
Year Ended December 31, 2017
|
||||||
|
Balance, beginning of year
|
$
|
2,048,381
|
|
|
$
|
1,993,428
|
|
|
$
|
1,993,428
|
|
|
Less reinsurance recoverables on unpaid losses and loss adjustment expenses
|
335,585
|
|
|
273,475
|
|
|
273,475
|
|
|||
|
Net balance, beginning of year
|
1,712,796
|
|
|
1,719,953
|
|
|
1,719,953
|
|
|||
|
Net losses:
|
|
|
|
|
|
||||||
|
Current year
|
152,572
|
|
|
147,927
|
|
|
603,518
|
|
|||
|
Favorable development of reserves established in prior years, net
|
(22,786
|
)
|
|
(28,776
|
)
|
|
(134,360
|
)
|
|||
|
Total
|
129,786
|
|
|
119,151
|
|
|
469,158
|
|
|||
|
Paid related to:
|
|
|
|
|
|
||||||
|
Current year
|
(14,243
|
)
|
|
(33,085
|
)
|
|
(106,633
|
)
|
|||
|
Prior years
|
(101,078
|
)
|
|
(80,709
|
)
|
|
(369,682
|
)
|
|||
|
Total paid
|
(115,321
|
)
|
|
(113,794
|
)
|
|
(476,315
|
)
|
|||
|
Net balance, end of period
|
1,727,261
|
|
|
1,725,310
|
|
|
1,712,796
|
|
|||
|
Plus reinsurance recoverables on unpaid losses and loss adjustment expenses
|
329,540
|
|
|
271,679
|
|
|
335,585
|
|
|||
|
Balance, end of period
|
$
|
2,056,801
|
|
|
$
|
1,996,989
|
|
|
$
|
2,048,381
|
|
|
(In thousands)
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Senior Notes due 2023, unsecured, interest at 5.3% annually
|
$
|
250,000
|
|
|
$
|
250,000
|
|
|
Revolving Credit Agreement, outstanding borrowings are fully secured, see Note 3, and carried at a weighted average interest rate of 2.24% and 1.91%, respectively. Outstanding borrowings are not permitted to exceed $250 million aggregately; Revolving Credit Agreement expires in 2020. The interest rate on the borrowings is set at the time the respective borrowing is initiated or renewed. The current borrowing can be repaid or renewed in the second quarter of 2018. If renewed, the interest rate will be reset.
|
83,000
|
|
|
123,000
|
|
||
|
Mortgage Loans, outstanding borrowings are secured by first priority liens on two office buildings, and bear an interest rate of three-month LIBOR plus 1.325% (3.42% and 2.86%, respectively) determined on a quarterly basis.
|
40,111
|
|
|
40,460
|
|
||
|
Total principal
|
373,111
|
|
|
413,460
|
|
||
|
Less debt issuance costs
|
1,583
|
|
|
1,649
|
|
||
|
Debt less debt issuance costs
|
$
|
371,528
|
|
|
$
|
411,811
|
|
|
($ in thousands)
|
March 31, 2018
|
|
December 31, 2017
|
|||||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location in the Condensed Consolidated Balance Sheets
|
Number of Instruments
|
Notional Amount
(1)
|
Estimated Fair Value
(2)
|
|
Number of Instruments
|
Notional Amount
(1)
|
Estimated Fair Value
(2)
|
||||||||
|
Interest Rate Cap
|
Other assets
|
1
|
$
|
35,000
|
|
$
|
2,306
|
|
|
1
|
$
|
35,000
|
|
$
|
1,731
|
|
|
(1)
Volume is represented by the derivative instrument's notional amount.
|
||||||||||||||||
|
(2)
Additional information regarding the fair value of the Company's interest rate cap is provided in Note 2.
|
||||||||||||||||
|
|
Gains (Losses) Recognized in
Income on Derivatives
|
|||||||
|
(In thousands)
|
Three Months Ended March 31
|
|||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location in the Condensed Consolidated Statements of Income and Comprehensive Income
|
2018
|
|
2017
|
||||
|
Interest Rate Cap
|
Interest expense
|
$
|
575
|
|
|
$
|
—
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Share-based compensation expense
|
$
|
902
|
|
|
$
|
3,346
|
|
|
Related tax benefits
|
$
|
190
|
|
|
$
|
1,171
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Reclassifications from AOCI to net income:
|
|
|
|
||||
|
Realized investment gains (losses)
|
$
|
2,417
|
|
|
$
|
1,616
|
|
|
Tax effect*
|
(508
|
)
|
|
(566
|
)
|
||
|
Net reclassification adjustments
|
$
|
1,909
|
|
|
$
|
1,050
|
|
|
|
|
|
|
||||
|
Deferred tax expense (benefit) included in OCI
|
$
|
(7,060
|
)
|
|
$
|
1,481
|
|
|
* Tax effects were computed using a 21% and 35% rate for the three months ended March 31, 2018 and 2017, respectively.
|
|||||||
|
(In thousands, except per share data)
|
Three Months Ended March 31
|
||||||
|
2018
|
|
2017
|
|||||
|
Weighted average number of common shares outstanding, basic
|
53,515
|
|
|
53,315
|
|
||
|
Dilutive effect of securities:
|
|
|
|
||||
|
Restricted Share Units
|
82
|
|
|
78
|
|
||
|
Performance Share Units
|
66
|
|
|
121
|
|
||
|
Purchase Match Units
|
19
|
|
|
21
|
|
||
|
Weighted average number of common shares outstanding, diluted
|
53,682
|
|
|
53,535
|
|
||
|
Effect of dilutive shares on earnings per share
|
$
|
—
|
|
|
$
|
(0.01
|
)
|
|
|
Three Months Ended March 31, 2018
|
||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
|
Net premiums earned
|
$
|
116,276
|
|
|
$
|
58,407
|
|
|
$
|
12,476
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
187,159
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
751
|
|
|
21,276
|
|
|
—
|
|
|
22,027
|
|
||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
1,640
|
|
|
—
|
|
|
1,640
|
|
||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
(54
|
)
|
|
(12,463
|
)
|
|
—
|
|
|
(12,517
|
)
|
||||||
|
Other income (expense)
|
1,256
|
|
|
366
|
|
|
331
|
|
|
943
|
|
|
(173
|
)
|
|
2,723
|
|
||||||
|
Net losses and loss adjustment expenses
|
(84,585
|
)
|
|
(36,715
|
)
|
|
(8,486
|
)
|
|
—
|
|
|
—
|
|
|
(129,786
|
)
|
||||||
|
Underwriting, policy acquisition and operating expenses
|
(28,276
|
)
|
|
(17,333
|
)
|
|
(7,246
|
)
|
|
(4,678
|
)
|
|
173
|
|
|
(57,360
|
)
|
||||||
|
Segregated portfolio cells dividend (expense) income
|
30
|
|
|
(1,894
|
)
|
|
—
|
|
|
117
|
|
|
—
|
|
|
(1,747
|
)
|
||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,705
|
)
|
|
—
|
|
|
(3,705
|
)
|
||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
3,428
|
|
|
—
|
|
|
3,422
|
|
||||||
|
Segment operating results
|
$
|
4,701
|
|
|
$
|
2,831
|
|
|
$
|
(2,234
|
)
|
|
$
|
6,558
|
|
|
$
|
—
|
|
|
$
|
11,856
|
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization, net of accretion
|
$
|
1,867
|
|
|
$
|
956
|
|
|
$
|
(1
|
)
|
|
$
|
3,257
|
|
|
$
|
—
|
|
|
$
|
6,079
|
|
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||||||
|
(In thousands)
|
Specialty P&C
|
|
Workers' Compensation
|
|
Lloyd's Syndicate
|
|
Corporate
|
|
Inter-segment Eliminations
|
|
Consolidated
|
||||||||||||
|
Net premiums earned
|
$
|
113,058
|
|
|
$
|
55,283
|
|
|
$
|
14,562
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
182,903
|
|
|
Net investment income
|
—
|
|
|
—
|
|
|
372
|
|
|
22,814
|
|
|
—
|
|
|
23,186
|
|
||||||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
—
|
|
|
—
|
|
|
—
|
|
|
1,808
|
|
|
—
|
|
|
1,808
|
|
||||||
|
Net realized gains (losses)
|
—
|
|
|
—
|
|
|
27
|
|
|
13,253
|
|
|
—
|
|
|
13,280
|
|
||||||
|
Other income (expense)
|
1,198
|
|
|
145
|
|
|
391
|
|
|
173
|
|
|
(86
|
)
|
|
1,821
|
|
||||||
|
Net losses and loss adjustment expenses
|
(74,994
|
)
|
|
(34,650
|
)
|
|
(9,507
|
)
|
|
—
|
|
|
—
|
|
|
(119,151
|
)
|
||||||
|
Underwriting, policy acquisition and operating expenses
|
(25,977
|
)
|
|
(16,691
|
)
|
|
(6,211
|
)
|
|
(8,315
|
)
|
|
86
|
|
|
(57,108
|
)
|
||||||
|
Segregated portfolio cells dividend (expense) income
|
28
|
|
|
(1,174
|
)
|
|
—
|
|
|
(1,229
|
)
|
|
—
|
|
|
(2,375
|
)
|
||||||
|
Interest expense
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,133
|
)
|
|
—
|
|
|
(4,133
|
)
|
||||||
|
Income tax benefit (expense)
|
—
|
|
|
—
|
|
|
7
|
|
|
1,217
|
|
|
—
|
|
|
1,224
|
|
||||||
|
Segment operating results
|
$
|
13,313
|
|
|
$
|
2,913
|
|
|
$
|
(359
|
)
|
|
$
|
25,588
|
|
|
$
|
—
|
|
|
$
|
41,455
|
|
|
Significant non-cash items:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization, net of accretion
|
$
|
1,911
|
|
|
$
|
837
|
|
|
$
|
(3
|
)
|
|
$
|
5,058
|
|
|
$
|
—
|
|
|
$
|
7,803
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Specialty P&C Segment
|
|
|
|
||||
|
Gross premiums earned:
|
|
|
|
||||
|
Healthcare professional liability
|
$
|
118,685
|
|
|
$
|
117,051
|
|
|
Legal professional liability
|
6,391
|
|
|
6,317
|
|
||
|
Medical technology liability
|
8,512
|
|
|
8,312
|
|
||
|
Other
|
110
|
|
|
102
|
|
||
|
Ceded premiums earned
|
(17,422
|
)
|
|
(18,724
|
)
|
||
|
Segment net premiums earned
|
116,276
|
|
|
113,058
|
|
||
|
|
|
|
|
||||
|
Workers' Compensation Segment
|
|
|
|
||||
|
Gross premiums earned:
|
|
|
|
||||
|
Traditional business
|
46,030
|
|
|
41,768
|
|
||
|
Alternative market business
|
19,381
|
|
|
19,446
|
|
||
|
Ceded premiums earned
|
(7,004
|
)
|
|
(5,931
|
)
|
||
|
Segment net premiums earned
|
58,407
|
|
|
55,283
|
|
||
|
|
|
|
|
||||
|
Lloyd's Syndicate Segment
|
|
|
|
||||
|
Gross premiums earned:
|
|
|
|
||||
|
Property and casualty*
|
17,967
|
|
|
17,185
|
|
||
|
Ceded premiums earned
|
(5,491
|
)
|
|
(2,623
|
)
|
||
|
Segment net premiums earned
|
12,476
|
|
|
14,562
|
|
||
|
|
|
|
|
||||
|
Consolidated net premiums earned
|
$
|
187,159
|
|
|
$
|
182,903
|
|
|
|
Distribution by GAAP Fair Value Hierarchy
|
|
|
|
|
||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Not Categorized
|
|
Total
Investments |
|
Investments recorded at:
|
|
|
|
|
|
|
|
|
|
|
Fair value
|
22%
|
|
63%
|
|
1%
|
|
9%
|
|
95%
|
|
Other valuations
|
|
|
|
|
|
|
|
|
5%
|
|
Total Investments
|
|
|
|
|
|
|
|
|
100%
|
|
(In millions)
|
Carrying Value
|
|
GAAP Measurement Method
|
||
|
Other investments:
|
|
|
|
||
|
Other, principally FHLB capital stock
|
$
|
2.9
|
|
|
Principally Cost
|
|
Investment in unconsolidated subsidiaries:
|
|
|
|
||
|
Investments in tax credit partnerships
|
86.2
|
|
|
Equity
|
|
|
Equity method investments, primarily LPs/LLCs
|
37.7
|
|
|
Equity
|
|
|
|
123.9
|
|
|
|
|
|
BOLI
|
62.6
|
|
|
Cash surrender value
|
|
|
Total investments - Other valuation methodologies
|
$
|
189.4
|
|
|
|
|
•
|
if there is intent to sell the security;
|
|
•
|
if it is more likely than not that the security will be required to be sold before full recovery of its amortized cost basis; and
|
|
•
|
if the entire amortized basis of the security is not expected to be recovered.
|
|
•
|
third-party research and credit rating reports;
|
|
•
|
the current credit standing of the issuer, including credit rating downgrades, whether before or after the balance sheet date;
|
|
•
|
the extent to which the decline in fair value is attributable to credit risk specifically associated with the security or its issuer;
|
|
•
|
internal assessments and the assessments of external portfolio managers regarding specific circumstances surrounding an investment, which indicate the investment is more or less likely to recover its amortized cost than other investments with a similar structure;
|
|
•
|
for asset-backed securities, the origination date of the underlying loans, the remaining average life, the probability that credit performance of the underlying loans will deteriorate in the future, and our assessment of the quality of the collateral underlying the loan;
|
|
•
|
failure of the issuer of the security to make scheduled interest or principal payments;
|
|
•
|
any changes to the rating of the security by a rating agency; and
|
|
•
|
recoveries or additional declines in fair value subsequent to the balance sheet date.
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018 vs 2017
|
|
2017 vs 2016
|
||||
|
Increase (decrease) in net cash provided (used) by:
|
|
|
|
||||
|
Operating activities
|
$
|
3,982
|
|
|
$
|
11,400
|
|
|
Investing activities
|
(39,574
|
)
|
|
218,506
|
|
||
|
Financing activities
|
(40,227
|
)
|
|
(201,547
|
)
|
||
|
Increase (decrease) in cash and cash equivalents
|
$
|
(75,819
|
)
|
|
$
|
28,359
|
|
|
|
Healthcare Professional Liability
|
|
Medical Technology & Life Sciences Products
|
|
Workers'
Compensation - Traditional
|
|
Per Occurrence Coverage
|
|
Aggregate Coverage
|
|
•
|
Reinsurance is utilized on a per risk basis for the property insurance and casualty coverages in order to mitigate risk volatility.
|
|
•
|
Catastrophic protection is utilized on both our property insurance and casualty coverages to protect against losses in excess of policy limits as well as natural catastrophes.
|
|
•
|
Both quota share reinsurance and excess of loss reinsurance are utilized to manage the net loss exposure on our property reinsurance coverages.
|
|
•
|
Property umbrella excess of loss reinsurance is utilized for peak catastrophe and frequency of catastrophe exposures.
|
|
•
|
Beginning in 2018, external excess of loss reinsurance will be utilized by Syndicate 1729 to manage the net loss exposure on the specialty property and contingency coverages ceded to Syndicate 6131 (see further discussion in Segment Operating Results - Lloyd's Syndicate section that follows).
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||
|
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
|
Fixed maturities, available for sale
|
|
|
|
|
|
||||||
|
U.S. Treasury obligations
|
$
|
129,751
|
|
4
|
%
|
|
$
|
133,627
|
|
4
|
%
|
|
U.S. Government-sponsored enterprise obligations
|
29,959
|
|
1
|
%
|
|
20,956
|
|
1
|
%
|
||
|
State and municipal bonds
|
329,995
|
|
9
|
%
|
|
632,243
|
|
17
|
%
|
||
|
Corporate debt
|
1,248,263
|
|
36
|
%
|
|
1,167,158
|
|
31
|
%
|
||
|
Residential mortgage-backed securities
|
215,420
|
|
6
|
%
|
|
197,844
|
|
5
|
%
|
||
|
Commercial mortgage-backed securities
|
44,082
|
|
1
|
%
|
|
26,703
|
|
1
|
%
|
||
|
Other asset-backed securities
|
156,213
|
|
5
|
%
|
|
101,711
|
|
3
|
%
|
||
|
Total fixed maturities, available for sale
|
2,153,683
|
|
62
|
%
|
|
2,280,242
|
|
62
|
%
|
||
|
|
|
|
|
|
|
||||||
|
Fixed maturities, trading
|
4,148
|
|
< 1%
|
|
|
—
|
|
—
|
%
|
||
|
Equity investments
|
492,159
|
|
14
|
%
|
|
470,609
|
|
13
|
%
|
||
|
Short-term investments
|
349,119
|
|
10
|
%
|
|
432,126
|
|
12
|
%
|
||
|
BOLI
|
62,562
|
|
2
|
%
|
|
62,113
|
|
1
|
%
|
||
|
Investment in unconsolidated subsidiaries
|
401,030
|
|
11
|
%
|
|
330,591
|
|
9
|
%
|
||
|
Other investments
|
35,944
|
|
1
|
%
|
|
110,847
|
|
3
|
%
|
||
|
Total investments
|
$
|
3,498,645
|
|
100
|
%
|
|
$
|
3,686,528
|
|
100
|
%
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||
|
($ in thousands)
|
Carrying
Value |
% of Total Investment
|
|
Carrying
Value |
% of Total Investment
|
||||||
|
Rating*
|
|
|
|
|
|
||||||
|
AAA
|
$
|
624,840
|
|
29
|
%
|
|
$
|
617,091
|
|
27
|
%
|
|
AA+
|
126,911
|
|
6
|
%
|
|
183,221
|
|
8
|
%
|
||
|
AA
|
102,636
|
|
5
|
%
|
|
173,488
|
|
8
|
%
|
||
|
AA-
|
145,247
|
|
7
|
%
|
|
195,110
|
|
9
|
%
|
||
|
A+
|
216,128
|
|
10
|
%
|
|
210,263
|
|
9
|
%
|
||
|
A
|
320,244
|
|
15
|
%
|
|
296,852
|
|
13
|
%
|
||
|
A-
|
205,556
|
|
10
|
%
|
|
202,581
|
|
9
|
%
|
||
|
BBB+
|
107,529
|
|
5
|
%
|
|
103,023
|
|
4
|
%
|
||
|
BBB
|
108,631
|
|
5
|
%
|
|
100,025
|
|
4
|
%
|
||
|
BBB-
|
49,475
|
|
2
|
%
|
|
48,207
|
|
2
|
%
|
||
|
Below investment grade
|
117,519
|
|
5
|
%
|
|
119,310
|
|
6
|
%
|
||
|
Not rated
|
28,967
|
|
1
|
%
|
|
31,071
|
|
1
|
%
|
||
|
Total
|
$
|
2,153,683
|
|
100
|
%
|
|
$
|
2,280,242
|
|
100
|
%
|
|
*Average of three NRSRO sources, presented as an S&P equivalent. Source: S&P, Copyright ©2017, S&P Global Market Intelligence
|
|||||||||||
|
|
Carrying Value
|
|
March 31, 2018
|
||||||||
|
($ in thousands, except expected funding period)
|
March 31, 2018
|
December 31, 2017
|
|
Unfunded Commitment
|
Expected funding period in years
|
||||||
|
Qualified affordable housing project tax credit partnerships
(1)
|
$
|
80,507
|
|
$
|
84,607
|
|
|
$
|
1,208
|
|
6
|
|
Historic tax credit partnerships
(2)
|
5,735
|
|
6,118
|
|
|
1,794
|
|
1
|
|||
|
All other investments, primarily investment fund LPs/LLCs
|
314,788
|
|
294,924
|
|
|
151,254
|
|
6
|
|||
|
Total
|
$
|
401,030
|
|
$
|
385,649
|
|
|
$
|
154,256
|
|
|
|
(1)
The carrying value reflects our total commitments (both funded and unfunded) to the partnerships, less any amortization, since our initial investment. We fund these investments based on funding schedules maintained by the partnerships.
|
|||||||||||
|
(2)
The carrying value reflects our funded commitments less any amortization.
|
|||||||||||
|
|
Three Months Ended March 31
|
|||||||||
|
($ in thousands, except per share data)
|
2018
|
2017
|
Change
|
|||||||
|
Revenues:
|
|
|
|
|
||||||
|
Net premiums written
|
$
|
215,132
|
|
$
|
204,227
|
|
$
|
10,905
|
|
|
|
Net premiums earned
|
$
|
187,159
|
|
$
|
182,903
|
|
$
|
4,256
|
|
|
|
Net investment result
|
23,667
|
|
24,994
|
|
(1,327
|
)
|
|
|||
|
Net realized investment gains (losses)
|
(12,517
|
)
|
13,280
|
|
(25,797
|
)
|
|
|||
|
Other income
|
2,723
|
|
1,821
|
|
902
|
|
|
|||
|
Total revenues
|
201,032
|
|
222,998
|
|
(21,966
|
)
|
|
|||
|
|
|
|
|
|
||||||
|
Expenses:
|
|
|
|
|
||||||
|
Net losses and loss adjustment expenses
|
129,786
|
|
119,151
|
|
10,635
|
|
|
|||
|
Underwriting, policy acquisition and operating expenses
|
57,360
|
|
57,108
|
|
252
|
|
|
|||
|
Segregated portfolio cells dividend expense (income)
|
1,747
|
|
2,375
|
|
(628
|
)
|
|
|||
|
Interest expense
|
3,705
|
|
4,133
|
|
(428
|
)
|
|
|||
|
Total expenses
|
192,598
|
|
182,767
|
|
9,831
|
|
|
|||
|
Income before income taxes
|
8,434
|
|
40,231
|
|
(31,797
|
)
|
|
|||
|
Income tax expense (benefit)
|
(3,422
|
)
|
(1,224
|
)
|
(2,198
|
)
|
|
|||
|
Net income
|
$
|
11,856
|
|
$
|
41,455
|
|
$
|
(29,599
|
)
|
|
|
Non-GAAP operating income
|
$
|
21,487
|
|
$
|
33,401
|
|
$
|
(11,914
|
)
|
|
|
Earnings per share:
|
|
|
|
|
||||||
|
Basic
|
$
|
0.22
|
|
$
|
0.78
|
|
$
|
(0.56
|
)
|
|
|
Diluted
|
$
|
0.22
|
|
$
|
0.77
|
|
$
|
(0.55
|
)
|
|
|
Non-GAAP operating earnings per share:
|
|
|
|
|
||||||
|
Basic
|
$
|
0.40
|
|
$
|
0.63
|
|
$
|
(0.23
|
)
|
|
|
Diluted
|
$
|
0.40
|
|
$
|
0.62
|
|
$
|
(0.22
|
)
|
|
|
Net loss ratio
|
69.3
|
%
|
65.1
|
%
|
4.2
|
|
pts
|
|||
|
Underwriting expense ratio
|
30.6
|
%
|
31.2
|
%
|
(0.6
|
)
|
pts
|
|||
|
Combined ratio
|
99.9
|
%
|
96.3
|
%
|
3.6
|
|
pts
|
|||
|
Operating ratio
|
88.1
|
%
|
83.6
|
%
|
4.5
|
|
pts
|
|||
|
Effective tax rate
|
(40.6
|
%)
|
(3.0
|
%)
|
(37.6
|
)
|
pts
|
|||
|
Return on equity*
|
3.0
|
%
|
9.1
|
%
|
(6.1
|
)
|
pts
|
|||
|
|
|
|
|
|
||||||
|
*Annualized
|
||||||||||
|
In all tables that follow, the abbreviation "nm" indicates that the information or the percentage change is not meaningful.
|
||||||||||
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net premiums earned
|
|
|
|
|
|
|
|
|||||||
|
Specialty P&C
|
$
|
116,276
|
|
|
$
|
113,058
|
|
|
$
|
3,218
|
|
|
2.8
|
%
|
|
Workers' Compensation
|
58,407
|
|
|
55,283
|
|
|
3,124
|
|
|
5.7
|
%
|
|||
|
Lloyd's Syndicate
|
12,476
|
|
|
14,562
|
|
|
(2,086
|
)
|
|
(14.3
|
%)
|
|||
|
Consolidated total
|
$
|
187,159
|
|
|
$
|
182,903
|
|
|
$
|
4,256
|
|
|
2.3
|
%
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
22,027
|
|
|
$
|
23,186
|
|
|
$
|
(1,159
|
)
|
|
(5.0
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
1,640
|
|
|
1,808
|
|
|
(168
|
)
|
|
(9.3
|
%)
|
|||
|
Net investment result
|
$
|
23,667
|
|
|
$
|
24,994
|
|
|
$
|
(1,327
|
)
|
|
(5.3
|
%)
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net impairment losses recognized in earnings
|
$
|
—
|
|
|
$
|
(171
|
)
|
|
$
|
171
|
|
|
nm
|
|
|
Other net realized investment gains (losses)
|
(12,517
|
)
|
|
13,451
|
|
|
(25,968
|
)
|
|
(193.1
|
%)
|
|||
|
Net realized investment gains (losses)
|
$
|
(12,517
|
)
|
|
$
|
13,280
|
|
|
$
|
(25,797
|
)
|
|
(194.3
|
%)
|
|
|
Three Months Ended March 31
|
|||||||||||
|
($ in millions)
|
2018
|
|
2017
|
|
Change
|
|||||||
|
Current accident year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
81.5
|
%
|
|
80.9
|
%
|
|
0.6
|
|
pts
|
|||
|
Specialty P&C
|
90.4
|
%
|
|
88.7
|
%
|
|
1.7
|
|
pts
|
|||
|
Workers' Compensation
|
66.1
|
%
|
|
67.0
|
%
|
|
(0.9
|
)
|
pts
|
|||
|
Lloyd's Syndicate
|
70.7
|
%
|
|
72.9
|
%
|
|
(2.2
|
)
|
pts
|
|||
|
|
|
|
|
|
|
|
||||||
|
Calendar year net loss ratio
|
|
|
|
|
|
|
||||||
|
Consolidated ratio
|
69.3
|
%
|
|
65.1
|
%
|
|
4.2
|
|
pts
|
|||
|
Specialty P&C
|
72.7
|
%
|
|
66.3
|
%
|
|
6.4
|
|
pts
|
|||
|
Workers' Compensation
|
62.9
|
%
|
|
62.7
|
%
|
|
0.2
|
|
pts
|
|||
|
Lloyd's Syndicate
|
68.0
|
%
|
|
65.3
|
%
|
|
2.7
|
|
pts
|
|||
|
|
|
|
|
|
|
|
||||||
|
Favorable (unfavorable) net loss development, prior accident years
|
|
|
|
|
|
|
||||||
|
Consolidated
|
$
|
22.8
|
|
|
$
|
28.8
|
|
|
$
|
(6.0
|
)
|
|
|
Specialty P&C
|
$
|
20.6
|
|
|
$
|
25.3
|
|
|
$
|
(4.7
|
)
|
|
|
Workers' Compensation
|
$
|
1.9
|
|
|
$
|
2.4
|
|
|
$
|
(0.5
|
)
|
|
|
Lloyd's Syndicate
|
$
|
0.3
|
|
|
$
|
1.1
|
|
|
$
|
(0.8
|
)
|
|
|
|
Three Months Ended March 31
|
||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||
|
Underwriting Expense Ratio
|
|
|
|
|
|
|
|||
|
Consolidated
|
30.6
|
%
|
|
31.2
|
%
|
|
(0.6
|
)
|
pts
|
|
Specialty P&C
|
24.3
|
%
|
|
23.0
|
%
|
|
1.3
|
|
pts
|
|
Workers' Compensation
|
29.7
|
%
|
|
30.2
|
%
|
|
(0.5
|
)
|
pts
|
|
Lloyd's Syndicate
|
58.1
|
%
|
|
42.7
|
%
|
|
15.4
|
|
pts
|
|
Corporate*
|
2.5
|
%
|
|
4.5
|
%
|
|
(2.0
|
)
|
pts
|
|
*There are no net premiums earned associated with the Corporate segment. Ratios shown are the contribution of the Corporate segment to the consolidated ratio (Corporate operating expenses divided by consolidated net premium earned).
|
|||||||||
|
|
Book Value Per Share
|
||
|
Book Value Per Share at December 31, 2017
|
$
|
29.83
|
|
|
Increase (decrease) to book value per share during the three months ended March 31, 2018 attributable to:
|
|
||
|
Dividends declared
|
(0.31
|
)
|
|
|
Net income
|
0.22
|
|
|
|
Decrease in AOCI
|
(0.49
|
)
|
|
|
Other
|
0.03
|
|
|
|
Book Value Per Share at March 31, 2018
|
$
|
29.28
|
|
|
|
Three Months Ended
March 31 |
||||||
|
(In thousands, except per share data)
|
2018
|
|
2017
|
||||
|
Net income
|
$
|
11,856
|
|
|
$
|
41,455
|
|
|
Items excluded in the calculation of Non-GAAP operating income:
|
|
|
|
||||
|
Net realized investment (gains) losses
|
12,517
|
|
|
(13,280
|
)
|
||
|
Net realized gains (losses) attributable to SPCs which no profit/loss is retained
(1)
|
(410
|
)
|
|
824
|
|
||
|
Guaranty fund assessments (recoupments)
|
84
|
|
|
65
|
|
||
|
Pre-tax effect of exclusions
|
12,191
|
|
|
(12,391
|
)
|
||
|
Tax effect
(2)
|
(2,560
|
)
|
|
4,337
|
|
||
|
After-tax effect of exclusions
|
$
|
9,631
|
|
|
$
|
(8,054
|
)
|
|
Non-GAAP operating income
|
$
|
21,487
|
|
|
$
|
33,401
|
|
|
Per diluted common share:
|
|
|
|
||||
|
Net income
|
$
|
0.22
|
|
|
$
|
0.77
|
|
|
Effect of exclusions
|
0.18
|
|
|
(0.15
|
)
|
||
|
Non-GAAP operating income per diluted common share
|
$
|
0.40
|
|
|
$
|
0.62
|
|
|
|
Three Months Ended March 31
|
|||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
|||||||||
|
Net premiums written
|
$
|
121,966
|
|
$
|
117,297
|
|
$
|
4,669
|
|
|
4.0
|
%
|
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
116,276
|
|
$
|
113,058
|
|
$
|
3,218
|
|
|
2.8
|
%
|
|
Other income
|
1,256
|
|
1,198
|
|
58
|
|
|
4.8
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(84,585
|
)
|
(74,994
|
)
|
(9,591
|
)
|
|
12.8
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(28,276
|
)
|
(25,977
|
)
|
(2,299
|
)
|
|
8.9
|
%
|
|||
|
Segregated portfolio cells dividend (expense) income
|
30
|
|
28
|
|
2
|
|
|
7.1
|
%
|
|||
|
Segment operating results
|
$
|
4,701
|
|
$
|
13,313
|
|
$
|
(8,612
|
)
|
|
(64.7
|
%)
|
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
72.7
|
%
|
66.3
|
%
|
6.4
|
|
pts
|
|||||
|
Underwriting expense ratio
|
24.3
|
%
|
23.0
|
%
|
1.3
|
|
pts
|
|||||
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums written
|
$
|
140,520
|
|
|
$
|
136,858
|
|
|
$
|
3,662
|
|
|
2.7
|
%
|
|
Less: Ceded premiums written
|
18,554
|
|
|
19,561
|
|
|
(1,007
|
)
|
|
(5.1
|
%)
|
|||
|
Net premiums written
|
$
|
121,966
|
|
|
$
|
117,297
|
|
|
$
|
4,669
|
|
|
4.0
|
%
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Professional liability
|
|
|
|
|
|
|
|
|||||||
|
Physicians
(1)
|
|
|
|
|
|
|
|
|||||||
|
Twelve month term
|
$
|
87,845
|
|
|
$
|
89,742
|
|
|
$
|
(1,897
|
)
|
|
(2.1
|
%)
|
|
Twenty-four month term
|
8,249
|
|
|
5,860
|
|
|
2,389
|
|
|
40.8
|
%
|
|||
|
Total Physicians
|
96,094
|
|
|
95,602
|
|
|
492
|
|
|
0.5
|
%
|
|||
|
Healthcare facilities
(2)(7)
|
15,083
|
|
|
12,170
|
|
|
2,913
|
|
|
23.9
|
%
|
|||
|
Other healthcare providers
(3)
|
8,991
|
|
|
8,740
|
|
|
251
|
|
|
2.9
|
%
|
|||
|
Legal professionals
(4)
|
7,799
|
|
|
7,892
|
|
|
(93
|
)
|
|
(1.2
|
%)
|
|||
|
Tail coverages
(5)
|
4,349
|
|
|
4,862
|
|
|
(513
|
)
|
|
(10.6
|
%)
|
|||
|
Total professional liability
|
132,316
|
|
|
129,266
|
|
|
3,050
|
|
|
2.4
|
%
|
|||
|
Medical technology liability
(6)
|
8,098
|
|
|
7,537
|
|
|
561
|
|
|
7.4
|
%
|
|||
|
Other
|
106
|
|
|
55
|
|
|
51
|
|
|
92.7
|
%
|
|||
|
Total
|
$
|
140,520
|
|
|
$
|
136,858
|
|
|
$
|
3,662
|
|
|
2.7
|
%
|
|
(1)
|
Physician policies were our greatest source of premium revenues in both
2018
and
2017
. The
decline
in twelve month term policies during the
2018
three-month period
was primarily driven by retention losses and, to a lesser extent, a timing difference related to the shifting in renewal date of one large policy. The decrease was largely offset by new business written, including the addition of one large policy and an increase in premiums assumed in which we participate on a quota share basis. We offer twenty-four month term policies to our physician insureds in one selected jurisdiction. The increase in twenty-four month premium, as compared to
2017
, primarily reflected the normal cycle of renewals (policies subject to renewal in
2018
were previously written in
2016
rather than in
2017
).
|
|
(2)
|
Our healthcare facilities premium (which includes hospitals, surgery centers and other facilities) increased during the
2018
three-month period
primarily due to an increase in coverage pertaining to one large entity which consolidated certain policies that were not previously insured by us and, to a lesser extent, timing differences related to the renewal of certain policies, partially offset by retention losses during the current period.
|
|
(3)
|
Our other healthcare providers are primarily dentists, chiropractors and allied health professionals. The increase during the
2018
three-month period
was driven by new business written, including a large policy with a multi-state dental group.
|
|
(4)
|
Our legal professionals policies are primarily individual and small group policies in select areas of practice. The slight decline during the
2018
three-month period
was primarily due to retention losses, offset almost entirely by new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies in select states due to rate filings. This increase in renewal pricing was the primary driver of retention losses during the period.
|
|
(5)
|
We offer extended reporting endorsement or "tail" coverage to insureds who discontinue their claims-made coverage with us, and we also periodically offer tail coverage through custom policies. The amount of tail coverage premium written can vary widely from period to period.
|
|
(6)
|
Our medical technology liability business is marketed throughout the U.S.; coverage is offered on a primary basis, within specified limits, to manufacturers and distributors of medical technology and life sciences products including entities conducting human clinical trials. In addition to the previously listed factors that affect our premium volume, our medical technology liability premium volume is impacted by the sales volume of insureds. The increase during the
2018
three-month period
primarily reflected new business written and, to a lesser extent, an increase in the rate charged for certain renewed policies, largely offset by retention losses. Retention losses are largely attributable to an increase in competition on terms and pricing.
|
|
(7)
|
Our alternative market solutions include writing healthcare premium in certain
SPC
s of our wholly owned Cayman Islands reinsurance subsidiaries,
Eastern Re
and
Inova Re
. We wrote healthcare professional liability premium in our healthcare facilities line of business of approximately
$3.2 million
and
$2.6 million
in the
2018
and
2017
three-month period
s, respectively. All or a portion of the premium written was ceded to the
SPC
s. Under the
SPC
structure, the operating results of each cell, net of any participation we have taken in the
SPC
s, accrue to the benefit of the external owners of that cell. Our
Specialty P&C
segment does not currently participate in the cells that write
HCPL
premium, and
|
|
|
Three Months Ended March 31
|
||||||
|
(In millions)
|
2018
|
|
2017
|
||||
|
Physicians
|
$
|
5.0
|
|
|
$
|
6.4
|
|
|
Healthcare facilities
|
2.1
|
|
|
1.0
|
|
||
|
Other healthcare providers
|
1.4
|
|
|
0.7
|
|
||
|
Legal professionals
|
0.8
|
|
|
0.9
|
|
||
|
Medical technology liability
|
0.9
|
|
|
1.2
|
|
||
|
Total
|
$
|
10.2
|
|
|
$
|
10.2
|
|
|
|
Three Months Ended March 31
|
||||
|
|
2018
|
|
2017
|
||
|
Physicians*
|
91
|
%
|
|
90
|
%
|
|
Healthcare facilities*
|
86
|
%
|
|
90
|
%
|
|
Other healthcare providers*
|
87
|
%
|
|
85
|
%
|
|
Legal professionals
|
82
|
%
|
|
84
|
%
|
|
Medical technology liability
|
87
|
%
|
|
80
|
%
|
|
* Excludes certain policies written on an excess and surplus lines basis.
|
|||||
|
|
Three Months Ended March 31
|
|
|
|
2018
|
|
|
Physicians
(1)
|
1
|
%
|
|
Healthcare facilities
(1)
|
3
|
%
|
|
Other healthcare providers
(1)
|
3
|
%
|
|
Legal professionals
(2)
|
6
|
%
|
|
Medical technology liability
|
5
|
%
|
|
(1)
Excludes certain policies written on an excess and surplus lines basis.
|
||
|
(2)
See Gross Premiums Written section for further explanation of renewal pricing increase.
|
||
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Excess of loss reinsurance arrangements
(1)
|
$
|
8,923
|
|
$
|
8,072
|
|
$
|
851
|
|
10.5
|
%
|
|
Premium ceded to Syndicate 1729
(2)
|
2,105
|
|
4,263
|
|
(2,158
|
)
|
(50.6
|
%)
|
|||
|
Other shared risk arrangements
(3)
|
8,513
|
|
8,446
|
|
67
|
|
0.8
|
%
|
|||
|
Other ceded premiums written
|
938
|
|
880
|
|
58
|
|
6.6
|
%
|
|||
|
Adjustment to premiums owed under reinsurance agreements, prior accident years, net
(4)
|
(1,925
|
)
|
(2,100
|
)
|
175
|
|
8.3
|
%
|
|||
|
Total ceded premiums written
|
$
|
18,554
|
|
$
|
19,561
|
|
$
|
(1,007
|
)
|
(5.1
|
%)
|
|
(1)
|
We generally reinsure risks under our excess of loss reinsurance arrangements pursuant to which the reinsurers agree to assume all or a portion of all risks that we insure above our individual risk retention levels, up to the maximum individual limits offered. In the majority of our excess of loss reinsurance arrangements, the premium due to the reinsurer is determined by the loss experience of that business reinsured, subject to certain minimum and maximum amounts. The increase in ceded premiums written under our excess of loss reinsurance arrangements for the
2018
three-month period
primarily reflected an increase in the premiums we expect to owe our reinsurers based upon an increase in our estimates of losses recoverable from our reinsurance partners.
|
|
(2)
|
As previously discussed, we are the majority participant in
Syndicate 1729
and normally record our pro rata share of its operating results in our
Lloyd's
Syndicate segment on a quarter delay, except when information is available that is material to the current period. We also record the cession to the
Lloyd's
Syndicate segment from our
Specialty P&C
segment on a quarter delay as the amounts are not material and this permits the cession to be reported by both the
Lloyd's
Syndicate segment and the
Specialty P&C
segment in the same reporting period. The decrease in premiums ceded to
Syndicate 1729
for the
2018
three-month period
reflected the revised contract terms effective January 1, 2017 which reduced the premiums ceded by essentially half. We did not renew our quota share agreement with
Syndicate 1729
on January 1, 2018, however the impact will not be reflected in ceded premiums until the second quarter of 2018 due to the previously mentioned quarter delay. See the Segment Operating Results -
Lloyd's
Syndicate section for further discussion on the quota share agreement. As our premiums are earned, we recognize the related ceding commission income which reduces underwriting expense by offsetting
DPAC
amortization. For the
2018
and
2017
three-month period
s the related ceding commission income was approximately
27%
of ceded premiums written. For our consolidated results, eliminations of the inter-segment portion (
58%
of the
Specialty P&C
cession) of the transactions are also recorded on a quarter delay.
|
|
(3)
|
We have entered into various shared risk arrangements, including quota share, fronting, and captive arrangements, with certain large healthcare systems and other insurance entities. These arrangements include our Ascension Health and CAPAssurance programs. While we cede a large portion of the premium written under these arrangements, they provide us an opportunity to grow net premium through strategic partnerships. The slight increase in the
2018
three-month period
was primarily driven by growth in our CAPAssurance program.
|
|
(4)
|
Given the length of time that it takes to resolve our claims, many years may elapse before all losses recoverable under a reinsurance arrangement are known. As a part of the process of estimating our loss reserve we also make estimates regarding the amounts recoverable under our reinsurance arrangements. As previously discussed, the premiums ultimately ceded under certain of our excess of loss reinsurance arrangements are subject to the losses ceded under the arrangements. Based upon adjustments in
2018
and
2017
three-month period
s to our estimate of expected losses and associated recoveries for prior year ceded losses, we reduced our estimate of ceded premiums owed to reinsurers. Changes to estimates of premiums ceded related to prior accident years are fully earned in the period the changes in estimates occur.
|
|
|
Three Months Ended March 31
|
|||||||
|
|
2018
|
|
2017
|
Change
|
||||
|
Ceded premiums ratio, as reported
|
13.2
|
%
|
|
14.3
|
%
|
(1.1
|
)
|
pts
|
|
Less the effect of adjustments in premiums owed under reinsurance agreements, prior accident years (as previously discussed)
|
(1.4
|
%)
|
|
(1.5
|
%)
|
0.1
|
|
pts
|
|
Ratio, current accident year
|
14.6
|
%
|
|
15.8
|
%
|
(1.2
|
)
|
pts
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Gross premiums earned
|
$
|
133,698
|
|
|
$
|
131,782
|
|
|
$
|
1,916
|
|
|
1.5
|
%
|
|
Less: Ceded premiums earned
|
17,422
|
|
|
18,724
|
|
|
(1,302
|
)
|
|
(7.0
|
%)
|
|||
|
Net premiums earned
|
$
|
116,276
|
|
|
$
|
113,058
|
|
|
$
|
3,218
|
|
|
2.8
|
%
|
|
|
Net Loss Ratios
(1)
|
|||||||
|
|
Three Months Ended March 31
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||
|
Calendar year net loss ratio
|
72.7
|
%
|
|
66.3
|
%
|
|
6.4
|
pts
|
|
Less impact of prior accident years on the net loss ratio
|
(17.7
|
%)
|
|
(22.4
|
%)
|
|
4.7
|
pts
|
|
Current accident year net loss ratio
|
90.4
|
%
|
|
88.7
|
%
|
|
1.7
|
pts
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
||
|
Ceded premium adjustments, prior accident years
(2)
|
(1.5
|
%)
|
|
(1.7
|
%)
|
|
0.2
|
pts
|
|
Current accident year net loss ratio, excluding the effect of prior year ceded premium
(3)
|
91.9
|
%
|
|
90.4
|
%
|
|
1.5
|
pts
|
|
(1)
|
Net losses, as specified, divided by net premiums earned.
|
|
(2)
|
Reductions to premiums owed under reinsurance agreements for prior accident years increased net premiums earned (the denominator of the current accident year ratio) for the
2018
and
2017
three-month period
s. See the discussion in the Premiums section for our
Specialty P&C
segment under the heading "Ceded Premiums Written" for additional information.
|
|
(3)
|
The current accident year net loss ratio for the
2018
three-month period
increased
1.5
percentage points when compared to the same respective period of
2017
. The increase was driven by both higher volume of earned premium as well as an increase in expected losses in our excess and surplus lines business, which resulted in a
1.9
percentage point increase in the current accident year net loss ratio when compared to the
2017
three-month period
. The increase was partially offset by the impact of the revision to our quota share reinsurance agreement with Syndicate 1729. Due to the revised contract terms, we are retaining more premium that carries a lower loss ratio as compared to the segment's total book of business which resulted in a
0.7
percentage point decrease in the current accident year net loss ratio when compared to the
2017
three-month period
.
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
DPAC amortization
|
$
|
13,034
|
|
|
$
|
11,185
|
|
|
$
|
1,849
|
|
|
16.5
|
%
|
|
Management fees
|
1,697
|
|
|
1,652
|
|
|
45
|
|
|
2.7
|
%
|
|||
|
Other underwriting and operating expenses
|
13,545
|
|
|
13,140
|
|
|
405
|
|
|
3.1
|
%
|
|||
|
Total
|
$
|
28,276
|
|
|
$
|
25,977
|
|
|
$
|
2,299
|
|
|
8.9
|
%
|
|
|
Three Months Ended March 31
|
|||||||
|
|
2018
|
|
2017
|
|
Change
|
|||
|
Underwriting expense ratio
|
24.3
|
%
|
|
23.0
|
%
|
|
1.3
|
pts
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
(In thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
SPC dividend (expense) income
|
$
|
30
|
|
|
$
|
28
|
|
|
$
|
2
|
|
|
7.1
|
%
|
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Net premiums written
|
$
|
81,325
|
|
$
|
75,570
|
|
$
|
5,755
|
|
7.6
|
%
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
58,407
|
|
$
|
55,283
|
|
$
|
3,124
|
|
5.7
|
%
|
|
Other income
|
366
|
|
145
|
|
221
|
|
152.4
|
%
|
|||
|
Net losses and loss adjustment expenses
|
(36,715
|
)
|
(34,650
|
)
|
(2,065
|
)
|
6.0
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(17,333
|
)
|
(16,691
|
)
|
(642
|
)
|
3.8
|
%
|
|||
|
Segregated portfolio cells dividend (expense) income
(1)
|
(1,894
|
)
|
(1,174
|
)
|
(720
|
)
|
61.3
|
%
|
|||
|
Segment operating results
|
$
|
2,831
|
|
$
|
2,913
|
|
$
|
(82
|
)
|
(2.8
|
%)
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
|
|
|
|
|||||||
|
Traditional business
|
65.2%
|
65.0%
|
0.2
|
|
pts
|
||||||
|
Alternative market business
|
56.6%
|
56.6%
|
—
|
|
pts
|
||||||
|
Segment results
|
62.9%
|
62.7%
|
0.2
|
|
pts
|
||||||
|
|
|
|
|
|
|||||||
|
Underwriting expense ratio
|
|
|
|
|
|||||||
|
Traditional business
|
29.3%
|
30.0%
|
(0.7
|
)
|
pts
|
||||||
|
Alternative market business
|
30.7%
|
30.6%
|
0.1
|
|
pts
|
||||||
|
Segment results
|
29.7%
|
30.2%
|
(0.5
|
)
|
pts
|
||||||
|
(1)
Represents the underwriting (profit) loss attributable to the alternative market business ceded to the SPCs at our Cayman Islands reinsurance subsidiaries, Eastern Re and Inova Re
,
net of our participation.
|
|||||||||||
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Gross premiums written
|
|
|
|
|
|||||||
|
Traditional business*
|
$
|
58,744
|
|
$
|
53,031
|
|
$
|
5,713
|
|
10.8
|
%
|
|
Alternative market business
|
32,605
|
|
31,199
|
|
1,406
|
|
4.5
|
%
|
|||
|
Segment results
|
91,349
|
|
84,230
|
|
7,119
|
|
8.5
|
%
|
|||
|
Less: Ceded premiums written
|
|
|
|
|
|||||||
|
Traditional business
|
3,581
|
|
1,955
|
|
1,626
|
|
83.2
|
%
|
|||
|
Alternative market business*
|
6,443
|
|
6,705
|
|
(262
|
)
|
(3.9
|
%)
|
|||
|
Segment results
|
10,024
|
|
8,660
|
|
1,364
|
|
15.8
|
%
|
|||
|
Net premiums written
|
|
|
|
|
|
|
|
||||
|
Traditional business
|
55,163
|
|
51,076
|
|
4,087
|
|
8.0
|
%
|
|||
|
Alternative market business
|
26,162
|
|
24,494
|
|
1,668
|
|
6.8
|
%
|
|||
|
Segment results
|
$
|
81,325
|
|
$
|
75,570
|
|
$
|
5,755
|
|
7.6
|
%
|
|
* Traditional gross premiums written and alternative market ceded premiums written are reported net of alternative market premiums assumed by our traditional business totaling $0.3 million and $0.2 million for the 2018 and 2017 three-month periods, respectively.
|
|||||||||||
|
|
Three Months Ended March 31
|
||||||||||||||||||
|
|
2018
|
|
2017
|
||||||||||||||||
|
($ in millions)
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||||||||
|
New business
|
$
|
13.7
|
|
$
|
2.9
|
|
$
|
16.6
|
|
|
$
|
9.4
|
|
$
|
4.6
|
|
$
|
14.0
|
|
|
Audit premium (including EBUB)
|
$
|
1.2
|
|
$
|
0.1
|
|
$
|
1.3
|
|
|
$
|
1.1
|
|
$
|
0.2
|
|
$
|
1.2
|
|
|
Retention rate
(1)
|
83
|
%
|
91
|
%
|
86
|
%
|
|
85
|
%
|
96
|
%
|
89
|
%
|
||||||
|
Change in renewal pricing
(2)
|
(4
|
%)
|
(1
|
%)
|
(3
|
%)
|
|
(4
|
%)
|
(4
|
%)
|
(3
|
%)
|
||||||
|
|
|
|
|
|
|
|
|
||||||||||||
|
(1)
We calculate our workers' compensation retention rate as annualized expiring renewed premium divided by all annualized expiring premium subject to renewal. Our retention rate can be impacted by various factors, including price or other competitive issues, insureds being acquired, or a decision not to renew based on our underwriting evaluation.
|
|||||||||||||||||||
|
(2)
The pricing of our business includes an assessment of the underlying policy exposure and the effects of current market conditions. We continue to base our pricing on expected losses, as indicated by our historical loss data. The renewal rate decreases reflected the competitive workers’ compensation environment.
|
|||||||||||||||||||
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Premiums ceded to external reinsurers
|
|
|
|
|
|||||||
|
Traditional business
|
$
|
2,907
|
|
$
|
2,759
|
|
$
|
148
|
|
5.4
|
%
|
|
Alternative market business
|
3,060
|
|
3,008
|
|
52
|
|
1.7
|
%
|
|||
|
Segment results
|
5,967
|
|
5,767
|
|
200
|
|
3.5
|
%
|
|||
|
Change in return premium estimate under external reinsurance
|
|
|
|
|
|
||||||
|
Traditional business
|
673
|
|
(804
|
)
|
1,477
|
|
183.7
|
%
|
|||
|
Alternative market business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
|
Segment results
|
673
|
|
(804
|
)
|
1,477
|
|
183.7
|
%
|
|||
|
Premiums ceded to unaffiliated captive insurers
|
|
|
|
|
|
||||||
|
Traditional business
|
—
|
|
—
|
|
—
|
|
nm
|
|
|||
|
Alternative market business
|
3,384
|
|
3,697
|
|
(313
|
)
|
(8.5
|
%)
|
|||
|
Segment results
|
3,384
|
|
3,697
|
|
(313
|
)
|
(8.5
|
%)
|
|||
|
Total ceded premiums written
|
|
|
|
|
|
|
|
|
|||
|
Traditional business
|
3,580
|
|
1,955
|
|
1,625
|
|
83.1
|
%
|
|||
|
Alternative market business
|
6,444
|
|
6,705
|
|
(261
|
)
|
(3.9
|
%)
|
|||
|
Segment results
|
$
|
10,024
|
|
$
|
8,660
|
|
$
|
1,364
|
|
15.8
|
%
|
|
|
Three Months Ended March 31
|
||||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||||
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Ceded premiums ratio, as reported
|
6.1%
|
19.8%
|
11.0%
|
|
3.7%
|
21.5%
|
10.3%
|
|
2.4
|
(1.7)
|
0.7
|
|
Less the effect of:
|
|
|
|
|
|
|
|
|
|
|
|
|
Return premium estimated under external reinsurance
|
1.1%
|
—%
|
0.7%
|
|
(1.5%)
|
—%
|
(1.0%)
|
|
2.6
|
—
|
1.7
|
|
Premiums ceded to unaffiliated captive insurers (100%)
|
—%
|
9.3%
|
3.4%
|
|
—%
|
10.6%
|
4.2%
|
|
—
|
(1.3)
|
(0.8)
|
|
Ceded premiums ratio, less the effects of above
|
5.0%
|
10.5%
|
6.9%
|
|
5.2%
|
10.9%
|
7.1%
|
|
(0.2)
|
(0.4)
|
(0.2)
|
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Gross premiums earned
|
|
|
|
|
|
||||||
|
Traditional business*
|
$
|
46,030
|
|
$
|
41,768
|
|
$
|
4,262
|
|
10.2
|
%
|
|
Alternative market business
|
19,381
|
|
19,446
|
|
(65
|
)
|
(0.3
|
%)
|
|||
|
Segment results
|
65,411
|
|
61,214
|
|
4,197
|
|
6.9
|
%
|
|||
|
Less: Ceded premiums earned
|
|
|
|
|
|
|
|||||
|
Traditional business
|
3,532
|
|
1,955
|
|
1,577
|
|
80.7
|
%
|
|||
|
Alternative market business*
|
3,472
|
|
3,976
|
|
(504
|
)
|
(12.7
|
%)
|
|||
|
Segment results
|
7,004
|
|
5,931
|
|
1,073
|
|
18.1
|
%
|
|||
|
Net premiums earned
|
|
|
|
|
|
|
|
|
|||
|
Traditional business
|
42,498
|
|
39,813
|
|
2,685
|
|
6.7
|
%
|
|||
|
Alternative market business
|
15,909
|
|
15,470
|
|
439
|
|
2.8
|
%
|
|||
|
Segment results
|
$
|
58,407
|
|
$
|
55,283
|
|
$
|
3,124
|
|
5.7
|
%
|
|
* Traditional gross premiums earned and alternative market ceded premiums earned are reported net of alternative market premiums assumed by our traditional business totaling $0.2 million and $0.1 million for the 2018 and 2017 three-month periods, respectively.
|
|||||||||||
|
|
Three Months Ended March 31
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
Change
|
||||||||||||||
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
||||||||
|
Calendar year net loss ratio*
|
65.2
|
%
|
56.6
|
%
|
62.9
|
%
|
|
65.0
|
%
|
56.6
|
%
|
62.7
|
%
|
|
0.2
|
—
|
|
0.2
|
|
|
Less impact of prior accident years on the net loss ratio
|
(0.9
|
%)
|
(9.6
|
%)
|
(3.2
|
%)
|
|
(1.0
|
%)
|
(12.9
|
%)
|
(4.3
|
%)
|
|
0.1
|
3.3
|
|
1.1
|
|
|
Current accident year net loss ratio
|
66.1
|
%
|
66.2
|
%
|
66.1
|
%
|
|
66.0
|
%
|
69.5
|
%
|
67.0
|
%
|
|
0.1
|
(3.3
|
)
|
(0.9
|
)
|
|
Less impact of audit premium on loss ratio
|
—
|
%
|
(0.3
|
%)
|
(0.1
|
%)
|
|
—
|
%
|
(0.8
|
%)
|
(0.2
|
%)
|
|
—
|
0.5
|
|
0.1
|
|
|
Current accident year net loss ratio, excluding the effect of audit premium
|
66.1
|
%
|
66.5
|
%
|
66.2
|
%
|
|
66.0
|
%
|
70.3
|
%
|
67.2
|
%
|
|
0.1
|
(3.8
|
)
|
(1.0
|
)
|
|
* The net loss ratios for the 2018 and 2017 three-month periods in the above tables are calculated before the impact of $0.2 million and $0.1 million, respectively, of premiums earned that is assumed by and ceded from the traditional and alternative markets business.
|
|||||||||||||||||||
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Traditional business
|
$
|
12,514
|
|
$
|
11,977
|
|
$
|
537
|
|
4.5
|
%
|
|
Alternative market business
|
4,819
|
|
4,714
|
|
105
|
|
2.2
|
%
|
|||
|
Underwriting, policy acquisition and operating expenses
|
$
|
17,333
|
|
$
|
16,691
|
|
$
|
642
|
|
3.8
|
%
|
|
|
Three Months Ended March 31
|
|||||||||||||||||||
|
|
2018
|
|
2017
|
|
Change
|
|||||||||||||||
|
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|
Traditional Business
|
Alternative Market Business
|
Segment
Results |
|||||||||
|
Underwriting expense ratio, as reported*
|
29.3
|
%
|
30.7
|
%
|
29.7
|
%
|
|
30.0
|
%
|
30.6
|
%
|
30.2
|
%
|
|
(0.7
|
)
|
0.1
|
|
(0.5
|
)
|
|
Less estimated ratio increase (decrease) attributable to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets
|
2.0
|
%
|
—
|
%
|
1.5
|
%
|
|
1.8
|
%
|
—
|
%
|
1.3
|
%
|
|
0.2
|
|
—
|
|
0.2
|
|
|
Management fee
|
1.6
|
%
|
—
|
%
|
1.2
|
%
|
|
1.6
|
%
|
—
|
%
|
1.1
|
%
|
|
—
|
|
—
|
|
0.1
|
|
|
Impact of audit premium
|
(0.7
|
%)
|
(0.1
|
%)
|
(0.6
|
%)
|
|
(0.7
|
%)
|
(0.3
|
%)
|
(0.6
|
%)
|
|
—
|
|
0.2
|
|
—
|
|
|
Impact of return premium estimate
|
0.4
|
%
|
—
|
%
|
0.3
|
%
|
|
(0.6
|
%)
|
—
|
%
|
(0.4
|
%)
|
|
1.0
|
|
—
|
|
0.7
|
|
|
Underwriting expense ratio, less listed effects
|
26.0
|
%
|
30.8
|
%
|
27.3
|
%
|
|
27.9
|
%
|
30.9
|
%
|
28.8
|
%
|
|
(1.9
|
)
|
(0.1
|
)
|
(1.5
|
)
|
|
* The underwriting expense ratios for the 2018 and 2017 three-month periods in the above tables are calculated before the impact of $0.2 million and $0.1 million, respectively, of premiums earned that is assumed by and ceded from the traditional and alternative markets business.
|
||||||||||||||||||||
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net premiums earned
|
$
|
15,707
|
|
|
$
|
15,417
|
|
|
$
|
290
|
|
|
1.9
|
%
|
|
Other income
|
30
|
|
|
20
|
|
|
10
|
|
|
50.0
|
%
|
|||
|
Less: Net losses and loss adjustment expenses
|
8,890
|
|
|
8,727
|
|
|
163
|
|
|
1.9
|
%
|
|||
|
Less: Underwriting, policy acquisition and operating expenses
|
4,819
|
|
|
4,714
|
|
|
105
|
|
|
2.2
|
%
|
|||
|
SPC net operating results - profit/(loss)
|
2,028
|
|
|
1,996
|
|
|
32
|
|
|
1.6
|
%
|
|||
|
Less: Eastern participation - profit/(loss)
|
134
|
|
|
822
|
|
|
(688
|
)
|
|
(83.7
|
%)
|
|||
|
SPC dividend expense (income)
|
$
|
1,894
|
|
|
$
|
1,174
|
|
|
$
|
720
|
|
|
61.3
|
%
|
|
|
Three Months Ended March 31
|
||||||||||
|
($ in thousands)
|
2018
|
2017
|
Change
|
||||||||
|
Gross premiums written
|
$
|
12,361
|
|
$
|
12,713
|
|
$
|
(352
|
)
|
(2.8
|
%)
|
|
Ceded premiums written
|
(520
|
)
|
(1,353
|
)
|
833
|
|
(61.6
|
%)
|
|||
|
Net premiums written
|
$
|
11,841
|
|
$
|
11,360
|
|
$
|
481
|
|
4.2
|
%
|
|
|
|
|
|
|
|||||||
|
Net premiums earned
|
$
|
12,476
|
|
$
|
14,562
|
|
$
|
(2,086
|
)
|
(14.3
|
%)
|
|
Net investment income
|
751
|
|
372
|
|
379
|
|
101.9
|
%
|
|||
|
Net realized gains (losses)
|
(54
|
)
|
27
|
|
(81
|
)
|
(300.0
|
%)
|
|||
|
Other income
|
331
|
|
391
|
|
(60
|
)
|
(15.3
|
%)
|
|||
|
Net losses and loss adjustment expenses
|
(8,486
|
)
|
(9,507
|
)
|
1,021
|
|
(10.7
|
%)
|
|||
|
Underwriting, policy acquisition and operating expenses
|
(7,246
|
)
|
(6,211
|
)
|
(1,035
|
)
|
16.7
|
%
|
|||
|
Income tax benefit (expense)
|
(6
|
)
|
7
|
|
(13
|
)
|
(185.7
|
%)
|
|||
|
Segment operating results
|
$
|
(2,234
|
)
|
$
|
(359
|
)
|
$
|
(1,875
|
)
|
522.3
|
%
|
|
|
|
|
|
|
|||||||
|
Net loss ratio
|
68.0
|
%
|
65.3
|
%
|
2.7
|
|
pts
|
||||
|
Underwriting expense ratio
|
58.1
|
%
|
42.7
|
%
|
15.4
|
|
pts
|
||||
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Net investment income
|
$
|
21,276
|
|
|
$
|
22,814
|
|
|
$
|
(1,538
|
)
|
|
(6.7
|
%)
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
1,640
|
|
|
$
|
1,808
|
|
|
$
|
(168
|
)
|
|
(9.3
|
%)
|
|
Net realized gains (losses)
|
$
|
(12,463
|
)
|
|
$
|
13,253
|
|
|
$
|
(25,716
|
)
|
|
(194.0
|
%)
|
|
Operating expense
|
$
|
4,678
|
|
|
$
|
8,315
|
|
|
$
|
(3,637
|
)
|
|
(43.7
|
%)
|
|
Segregated portfolio cells dividend expense (income)
(1)
|
$
|
(117
|
)
|
|
$
|
1,229
|
|
|
$
|
(1,346
|
)
|
|
(109.5
|
%)
|
|
Interest expense
|
$
|
3,705
|
|
|
$
|
4,133
|
|
|
$
|
(428
|
)
|
|
(10.4
|
%)
|
|
Income tax expense (benefit)
|
$
|
(3,428
|
)
|
|
$
|
(1,217
|
)
|
|
$
|
(2,211
|
)
|
|
(181.7
|
%)
|
|
(1)
Represents the investment results attributable to the SPCs at our Cayman Islands reinsurance subsidiaries.
|
||||||||||||||
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Fixed maturities
|
$
|
16,391
|
|
|
$
|
19,725
|
|
|
$
|
(3,334
|
)
|
|
(16.9
|
%)
|
|
Equities
|
4,867
|
|
|
3,644
|
|
|
1,223
|
|
|
33.6
|
%
|
|||
|
Short-term investments, including Other
|
1,220
|
|
|
778
|
|
|
442
|
|
|
56.8
|
%
|
|||
|
BOLI
|
449
|
|
|
455
|
|
|
(6
|
)
|
|
(1.3
|
%)
|
|||
|
Investment fees and expenses
|
(1,651
|
)
|
|
(1,788
|
)
|
|
137
|
|
|
(7.7
|
%)
|
|||
|
Net investment income
|
$
|
21,276
|
|
|
$
|
22,814
|
|
|
$
|
(1,538
|
)
|
|
(6.7
|
%)
|
|
|
Three Months Ended March 31
|
||
|
|
2018
|
|
2017
|
|
Average income yield
|
3.2%
|
|
3.2%
|
|
Average tax equivalent income yield
|
3.3%
|
|
3.6%
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
All other investments, primarily investment fund LPs/LLCs
|
$
|
7,616
|
|
|
$
|
5,533
|
|
|
$
|
2,083
|
|
|
37.6
|
%
|
|
Tax credit partnerships
|
(5,976
|
)
|
|
(3,725
|
)
|
|
(2,251
|
)
|
|
60.4
|
%
|
|||
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
$
|
1,640
|
|
|
$
|
1,808
|
|
|
$
|
(168
|
)
|
|
(9.3
|
%)
|
|
|
Three Months Ended March 31
|
||||||
|
(In millions)
|
2018
|
|
2017
|
||||
|
Tax credits recognized during the period
|
$
|
5.3
|
|
|
$
|
6.4
|
|
|
Tax benefit of tax credit partnership operating losses
|
$
|
1.3
|
|
|
$
|
1.3
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
GAAP net investment result:
|
|
|
|
||||
|
Net investment income
|
$
|
21,276
|
|
|
$
|
22,814
|
|
|
Equity in earnings (loss) of unconsolidated subsidiaries
|
1,640
|
|
|
1,808
|
|
||
|
GAAP net investment result
|
$
|
22,916
|
|
|
$
|
24,622
|
|
|
|
|
|
|
||||
|
Pro forma tax-equivalent investment result
|
$
|
30,749
|
|
|
$
|
37,971
|
|
|
|
|
|
|
||||
|
Reconciliation of pro forma and GAAP tax-equivalent investment result:
|
|
|
|
||||
|
GAAP net investment result
|
$
|
22,916
|
|
|
$
|
24,622
|
|
|
Taxable equivalent adjustments, calculated using the 21% and 35% federal statutory tax rate for 2018 and 2017, respectively:
|
|
|
|
||||
|
State and municipal bonds
|
698
|
|
|
2,498
|
|
||
|
BOLI
|
119
|
|
|
245
|
|
||
|
Dividends received
|
339
|
|
|
734
|
|
||
|
Tax credit partnerships
|
6,677
|
|
|
9,872
|
|
||
|
Pro forma tax-equivalent investment result
|
$
|
30,749
|
|
|
$
|
37,971
|
|
|
|
Three Months Ended March 31
|
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
OTTI losses, total:
|
|
|
|
||||
|
Corporate debt
|
$
|
—
|
|
|
$
|
(419
|
)
|
|
Portion of OTTI losses recognized in other comprehensive income before taxes:
|
|
|
|
||||
|
Corporate debt
|
—
|
|
|
248
|
|
||
|
Net impairment losses recognized in earnings
|
—
|
|
|
(171
|
)
|
||
|
Gross realized gains, available-for-sale fixed maturities
|
4,464
|
|
|
1,842
|
|
||
|
Gross realized (losses), available-for-sale fixed maturities
|
(2,042
|
)
|
|
(66
|
)
|
||
|
Net realized gains (losses), equity investments
|
9,219
|
|
|
6,562
|
|
||
|
Net realized gains (losses), other investments
|
688
|
|
|
1,172
|
|
||
|
Change in unrealized holding gains (losses), equity investments
|
(23,845
|
)
|
|
3,599
|
|
||
|
Change in unrealized holding gains (losses), convertible securities, carried at fair value as a part of other investments
|
(954
|
)
|
|
313
|
|
||
|
Other
|
7
|
|
|
2
|
|
||
|
Net realized investment gains (losses)
|
$
|
(12,463
|
)
|
|
$
|
13,253
|
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Operating expenses
|
$
|
8,637
|
|
|
$
|
12,135
|
|
|
$
|
(3,498
|
)
|
|
(28.8
|
%)
|
|
Management fee offset
|
(3,959
|
)
|
|
(3,820
|
)
|
|
(139
|
)
|
|
3.6
|
%
|
|||
|
Segment Total
|
$
|
4,678
|
|
|
$
|
8,315
|
|
|
$
|
(3,637
|
)
|
|
(43.7
|
%)
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
SPC dividend expense (income)
|
$
|
(117
|
)
|
|
$
|
1,229
|
|
|
$
|
(1,346
|
)
|
|
(109.5
|
%)
|
|
|
Three Months Ended March 31
|
|||||||||||||
|
($ in thousands)
|
2018
|
|
2017
|
|
Change
|
|||||||||
|
Senior Notes due 2023
|
$
|
3,357
|
|
|
$
|
3,357
|
|
|
$
|
—
|
|
|
—
|
%
|
|
Revolving Credit Agreement (including fees and amortization)
|
607
|
|
|
767
|
|
|
(160
|
)
|
|
(20.9
|
%)
|
|||
|
Mortgage Loans (including amortization)
|
306
|
|
|
—
|
|
|
306
|
|
|
nm
|
|
|||
|
(Gain)/loss on interest rate cap
|
(575
|
)
|
|
—
|
|
|
(575
|
)
|
|
nm
|
|
|||
|
Other
|
10
|
|
|
9
|
|
|
1
|
|
|
11.1
|
%
|
|||
|
Interest expense
|
$
|
3,705
|
|
|
$
|
4,133
|
|
|
$
|
(428
|
)
|
|
(10.4
|
%)
|
|
|
Three Months Ended
March 31 |
||||||
|
(In thousands)
|
2018
|
|
2017
|
||||
|
Corporate segment income tax expense (benefit)
|
$
|
(3,428
|
)
|
|
$
|
(1,217
|
)
|
|
Lloyd's Syndicate segment income tax expense (benefit)
|
6
|
|
|
(7
|
)
|
||
|
Consolidated income tax expense (benefit)
|
$
|
(3,422
|
)
|
|
$
|
(1,224
|
)
|
|
|
Three Months Ended
March 31 |
||||
|
|
2018
|
|
2017
|
||
|
Statutory rate
(1)
|
21.0
|
%
|
|
35.0
|
%
|
|
Tax-exempt income
(2)
|
(11.8
|
%)
|
|
(7.1
|
%)
|
|
Tax credits
|
(62.5
|
%)
|
|
(23.0
|
%)
|
|
Non-U.S. operating results
|
5.5
|
%
|
|
—
|
%
|
|
Excess tax benefit on share-based compensation
|
(0.5
|
%)
|
|
(5.8
|
%)
|
|
Other
|
7.7
|
%
|
|
(2.1
|
%)
|
|
Effective tax rate
|
(40.6
|
%)
|
|
(3.0
|
%)
|
|
(1)
Effective January 1, 2018, the corporate statutory tax rate changed from 35% to 21% as a result of tax reform enacted by the TCJA.
|
|||||
|
(2)
Includes tax-exempt interest, dividends received deduction and change in cash surrender value of BOLI.
|
|||||
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
|
March 31, 2018
|
||||||||||||||||||
|
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
|
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
138
|
|
|
$
|
134
|
|
|
$
|
130
|
|
|
$
|
126
|
|
|
$
|
122
|
|
|
U.S. Government-sponsored enterprise obligations
|
31
|
|
|
31
|
|
|
30
|
|
|
29
|
|
|
27
|
|
|||||
|
State and municipal bonds
|
353
|
|
|
341
|
|
|
330
|
|
|
319
|
|
|
308
|
|
|||||
|
Corporate debt
|
1,359
|
|
|
1,313
|
|
|
1,248
|
|
|
1,225
|
|
|
1,184
|
|
|||||
|
Asset-backed securities
|
439
|
|
|
428
|
|
|
416
|
|
|
400
|
|
|
385
|
|
|||||
|
Total fixed maturities, available for sale
|
$
|
2,320
|
|
|
$
|
2,247
|
|
|
$
|
2,154
|
|
|
$
|
2,099
|
|
|
$
|
2,026
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
3.11
|
|
|
3.02
|
|
|
2.94
|
|
|
2.87
|
|
|
2.79
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
1.31
|
|
|
1.73
|
|
|
3.92
|
|
|
4.87
|
|
|
5.23
|
|
|||||
|
State and municipal bonds
|
3.39
|
|
|
3.37
|
|
|
3.39
|
|
|
3.47
|
|
|
3.57
|
|
|||||
|
Corporate debt
|
3.47
|
|
|
3.44
|
|
|
3.47
|
|
|
3.45
|
|
|
3.41
|
|
|||||
|
Asset-backed securities
|
2.17
|
|
|
2.72
|
|
|
3.40
|
|
|
3.80
|
|
|
3.97
|
|
|||||
|
Total fixed maturities, available for sale
|
3.16
|
|
|
3.24
|
|
|
3.42
|
|
|
3.50
|
|
|
3.53
|
|
|||||
|
|
Interest Rate Shift in Basis Points
|
||||||||||||||||||
|
|
December 31, 2017
|
||||||||||||||||||
|
($ in millions)
|
(200)
|
|
(100)
|
|
Current
|
|
100
|
|
200
|
||||||||||
|
Fair Value:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
$
|
142
|
|
|
$
|
138
|
|
|
$
|
134
|
|
|
$
|
130
|
|
|
$
|
126
|
|
|
U.S. Government-sponsored enterprise obligations
|
22
|
|
|
21
|
|
|
21
|
|
|
20
|
|
|
19
|
|
|||||
|
State and municipal bonds
|
683
|
|
|
657
|
|
|
632
|
|
|
609
|
|
|
585
|
|
|||||
|
Corporate debt
|
1,249
|
|
|
1,208
|
|
|
1,167
|
|
|
1,128
|
|
|
1,090
|
|
|||||
|
Asset-backed securities
|
341
|
|
|
335
|
|
|
326
|
|
|
315
|
|
|
302
|
|
|||||
|
Total fixed maturities, available for sale
|
$
|
2,437
|
|
|
$
|
2,359
|
|
|
$
|
2,280
|
|
|
$
|
2,202
|
|
|
$
|
2,122
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Duration:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fixed maturities, available for sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
U.S. Treasury obligations
|
3.11
|
|
|
3.02
|
|
|
2.94
|
|
|
2.86
|
|
|
2.79
|
|
|||||
|
U.S. Government-sponsored enterprise obligations
|
1.38
|
|
|
1.34
|
|
|
3.59
|
|
|
4.58
|
|
|
4.87
|
|
|||||
|
State and municipal bonds
|
3.83
|
|
|
3.79
|
|
|
3.78
|
|
|
3.80
|
|
|
3.85
|
|
|||||
|
Corporate debt
|
3.37
|
|
|
3.33
|
|
|
3.38
|
|
|
3.38
|
|
|
3.34
|
|
|||||
|
Asset-backed securities
|
1.72
|
|
|
2.21
|
|
|
3.15
|
|
|
3.89
|
|
|
4.24
|
|
|||||
|
Total fixed maturities, available for sale
|
3.23
|
|
|
3.26
|
|
|
3.43
|
|
|
3.55
|
|
|
3.59
|
|
|||||
|
(a)
|
Not applicable.
|
|
(b)
|
Not applicable.
|
|
(c)
|
Information required by Item 703 of Regulation S-K.
|
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs* (In thousands)
|
||
|
January 1 - 31, 2018
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
|
February 1 - 28, 2018
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
|
March 1 - 31, 2018
|
|
—
|
|
|
N/A
|
|
—
|
|
|
$109,643
|
|
Total
|
|
—
|
|
|
$—
|
|
—
|
|
|
|
|
*
|
Under its current plan begun in November 2010, the Board has authorized
$600 million
for the repurchase of common shares or the retirement of outstanding debt. This is ProAssurance’s only plan for the repurchase of common shares, and the plan has no expiration date.
|
|
Exhibit Number
|
|
Description
|
|
|
|
|
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC rule 13a-14(a).
|
|
|
|
|
|
|
|
Certification of Principal Financial and Accounting Officer of ProAssurance as required under SEC rule 13a-14(a).
|
|
|
|
|
|
|
|
Certification of Principal Executive Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350).
|
|
|
|
|
|
|
|
Certification of Principal Financial and Accounting Officer of ProAssurance as required under SEC Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as amended (18 U.S.C. 1350).
|
|
|
|
|
|
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
|
|
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
PROASSURANCE CORPORATION
|
|
/s/ Edward L. Rand, Jr.
|
|
Edward L. Rand, Jr.
|
|
Chief Operating Officer and Chief Financial Officer
|
|
(Duly authorized officer and principal financial officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|